DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	IGKV1D-8; IGLV3-21; IGLV7-46; IGLV5-45; IGLV3-19; IGLV9-49; IGLV2-14; IGLV4-69; IGLV2-23; IGLV6-57; IGLV2-11; IGLV1-40; IGLV3-1; IGLV8-61; IGLV2-18; IGLV7-43; IGLV3-9; IGLV3-27; IGLV1-47; IGLV3-10; IGLV10-54;	GO:0002377~immunoglobulin production	21	107	19.6261682242991	0	0	0	0	0	0	0
down	KLK10; KLK8; LTF; ELANE; MMP3; CTSG; AZU1; GZMH; ENDOU; MMP8; PRSS3; KLK7; ADAM15; PRSS8; GGT6; TMPRSS11F; PRSS33; ADAMTS14; GGH; SCRN2; CAPNS2; PRSS27; TMPRSS13; PRSS22; TMPRSS4; KLK11; KLK12; TMPRSS11E; KLK5; CAPN6; CAPN14; THOP1; CPA4;	GO:0006508~proteolysis	33	436	7.56880733944954	0	0	0	0	0	0	0
down	IGLC7; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-19; IGLV3-1; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-48; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHA1; IGHA2; IGLV7-43; ADRB2; SAA1; IGLC3; FOLR2; FCGR2B; HBA1; IGLV3-21;	GO:0006898~receptor-mediated endocytosis	30	160	18.75	0	0	0	0	0	0	0
down	IGHV4-39; IGHV1-69; IGLL5; IGHG2; IGHV3-30; TRDC; IGHV1-46; IGHV3-72; IGHA2; IGHA1; IGHV1-3; IGHG4; IGHV3-15; IGHV3-49; IGHV1-69-2; IGHV3-20; IGHV3-21; IGLC7; IGLC3; IGHE; IGHV3-53; IGHG3; IGHV3-7; IGHV2-5; IGHD; IGHV2-26; IGHV3-73; IGKC; IGHV6-1; IGHV3-48; IGHV1-24; IGHV4-59;	GO:0006910~phagocytosis, recognition	32	99	32.3232323232323	0	0	0	0	0	0	0
down	FCGR2B; IGHG2; IGHV3-30; IGHE; IGHV2-26; IGHV3-53; IGHV1-24; IGHV3-7; IGHA1; IGHV3-72; IGHA2; IGHV3-20; IGHV3-21; IGHV2-5; TRDC; IGHV1-69; IGLC7; IGHV4-39; IGHV3-49; IGHV1-3; IGHV1-46; IGHV4-59; IGHV3-73; IGHV3-15; IGHV1-69-2; IGHV6-1; IGHG3; IGHV3-48; IGKC; IGLC3; IGHG4; IGHD; IGLL5;	GO:0006911~phagocytosis, engulfment	33	115	28.695652173913	0	0	0	0	0	0	0
down	NCR3; LY86; ORM1; ANXA1; KRT16; FOLR2; ALOX15; AZU1; BDKRB2; FCGR2B; CARD18; GSDMD; ELF3; FUT7; IL18; ECM1; AOC3; NLRP10; PLD4; MGLL; PROK2; PF4; PTGDR; IL36A; ACKR1; PF4V1; CCL26; IL36G; IL36RN; XCL1;	GO:0006954~inflammatory response	30	381	7.8740157480315	0	0	0	0	0	0	0
down	NCR3; CXCL14; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-19; IGLV3-1; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-48; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHE; IGHA1; IGHA2; IGHD; SLPI; IGLV7-43; CTSG; CD8B; GZMA; ENDOU; HRH2; FCGR2B; CD79B; DEFB1; IGLV3-21; GBP6; IL36A; IGKV1D-8; IGLV8-61; IGLV5-45; IGLV10-54; CXCR1; IGLV9-49; IGLV7-46; CD1C; PF4V1; IGLV4-69; IGLV3-9; IGLV2-18; RAET1L; PF4; RAET1E; IGLV3-10;	GO:0006955~immune response	54	433	12.4711316397229	0	0	0	0	0	0	0
down	IGLC7; FCN1; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-19; IGLV3-1; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-48; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; IGLV7-43; IGLC3; IGLV3-21;	GO:0006956~complement activation	28	92	30.4347826086957	0	0	0	0	0	0	0
down	IGLC7; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-19; IGLV3-1; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-48; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; IGLV7-43; IGLC3; IGLV3-21; TRDC; IGHV3-21; IGHV3-20; IGHD; IGHV1-24; IGHV1-69-2; IGHV3-49; IGLL5; IGHV2-26; IGHV3-15; IGHV6-1; IGHE; IGHV1-3; IGHV3-72; IGHA2; IGHA1; IGHV3-73;	GO:0006958~complement activation, classical pathway	44	161	27.3291925465839	0	0	0	0	0	0	0
down	AGPAT2; FOXN1; SCEL; GJB5; KRT14; KRT5; DSP; KRT15; SPRR2D; CRABP2; KRT9; KLK7; EMP1; ELF3; FABP5; CST6; ZNF750; CERS3; GRHL3; EVPL; GRHL1; SPRR3; POU2F3; KLK5; KRTDAP;	GO:0008544~epidermis development	25	82	30.4878048780488	0	0	0	0	0	0	0
down	IGLC7; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-19; IGLV3-1; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-48; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; C1QA; IGLV7-43; IGLC3; CD19; IGLV3-21; CR1L;	GO:0030449~regulation of complement activation	29	113	25.6637168141593	0	0	0	0	0	0	0
down	KRT86; KRT14; KRT6A; KRT6B; KRT1; KRT18; KRT7; KRT16; KRT10; KRT13; KRT5; JUP; DSP; KRT15; KRT4; SFN; DSG3; KRT9; KRT6C; KRT76; DSG1; DSC2; KRT17; PKP1; DSC3; KRT80; HRNR; KRT78; CNFN; KRT23; PKP3;	GO:0031424~keratinization	31	181	17.1270718232044	0	0	0	0	0	0	0
down	IGLC7; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-19; IGLV3-1; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-48; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHE; IGLV7-43; IGLC3; IGLV3-21;	GO:0038095~Fc-epsilon receptor signaling pathway	24	171	14.0350877192982	0	0	0	0	0	0	0
down	IGLC7; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-19; IGLV3-1; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-48; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGHG2; IGHG3; IGHG4; IGLV7-43; IGLC3; FCGR2B; IGLV3-21;	GO:0038096~Fc-gamma receptor signaling pathway involved in phagocytosis	27	135	20	0	0	0	0	0	0	0
down	ELANE; ANXA3; DEFB1; ROMO1; LCN2; CEBPE; GBP6; WFDC12; S100A14; IGHV3-48; IGHV6-1; GSDMA; IGHG2; IGLC3; IGHG3; IGHV1-46; IGHV3-53; IGHV1-24; IGHV3-73; IGHA1; IGHV3-30; IGHA2; IGHV3-72; IGLL5; IGHV2-5; IGHD; IGHV3-49; IGHV3-7; GSDMC; IGHE; IGHV3-15; IGHV1-69; IGHV1-69-2; IGLC7; TRDC; IGHV3-20; IGKC; IGHV4-39; IGHV2-26; IGHV3-21; GSDMD; IGHV4-59; IGHV1-3; IGHG4;	GO:0042742~defense response to bacterium	44	216	20.3703703703704	0	0	0	0	0	0	0
down	FCN1; AGPAT2; SIGLEC5; ORM1; LTF; SLPI; CSTB; KRT1; ELANE; CTSG; GSTP1; ALDOC; RNASE2; ANXA3; RNASE3; DEFA4; JUP; DSP; BPI; GM2A; AOC1; AZU1; MMP8; CXCR1; S100P; PRSS3; CEACAM3; CEACAM6; MNDA; HK3; CRISP3; GSDMD; VAMP2; DYNLL1; LCN2; FABP5; DSG1; PRDX4; PKP1; HRNR; GGH; MS4A3; SERPINB12; ADGRE3; RETN; CD300A;	GO:0043312~neutrophil degranulation	46	483	9.52380952380952	0	0	0	0	0	0	0
down	LILRA5; LY86; C1QA; SLPI; ANXA1; S100B; KRT16; SAA1; RNASE3; DEFA4; IFI27; CRISP3; GSDMD; DEFB1; LCN2; KLRD1; ADAM15; TRIM29; NLRX1; NLRP10; CLEC10A; ZNF683; LILRA2; RNASE6; PLD4; PGLYRP4; PGLYRP3; SIGLEC10; WRNIP1; SPON2; RNASE7; IL36G; IL36RN; TRIM10; IL36A; TRDC; IGHV3-15; IGHA1; IGHV3-48; IGHV1-69-2; IGHV2-26; IGHV4-59; IGHV4-39; IGHV3-53; IGHV1-3; IGHV3-30; IGLC3; IGHV3-49; IGLC7; IGHV3-21; IGHV6-1; IGHV3-7; IGHV3-72; IGHV1-46; IGHG4; IGHA2; IGLL5; IGHV1-24; IGHV3-73; IGHG3; BPI; IGHV1-69; IGKC; IGHV2-5; IGHE; IGHD; IGHG2; IGHV3-20;	GO:0045087~innate immune response	68	505	13.4653465346535	0	0	0	0	0	0	0
down	IGLC7; NCR3; IGLV1-47; IGLV1-40; IGLV2-14; IGLV2-23; IGLV2-11; IGLV3-19; IGLV3-1; IGLV3-27; IGLV6-57; IGHV1-69; IGHV1-46; IGHV3-48; IGHV3-53; IGHV3-30; IGHV3-7; IGHV2-5; IGHV4-39; IGHV4-59; IGKC; IGLV7-43; IGLC3; CD8B; CD19; CD1C; FCGR2B; ICAM3; IGLV3-21; KLRD1; RAET1E; CD300A; SIGLEC7; BTNL8; BTNL3;	GO:0050776~regulation of immune response	35	216	16.2037037037037	0	0	0	0	0	0	0
down	CD19; MNDA; IGHV3-72; IGHV3-21; IGHV4-39; IGHV1-69-2; IGHV2-5; IGHV2-26; IGLL5; IGLC3; IGHV3-30; CD79B; IGHG2; IGHV1-3; IGHV1-69; IGHV3-73; IGHG4; IGHA1; IGHV1-46; IGHV4-59; IGHV6-1; IGHG3; IGHV1-24; IGLC7; IGHA2; IGHV3-20; TRDC; IGHE; IGHD; IGHV3-15; IGHV3-48; IGHV3-53; IGHV3-49; IGHV3-7; IGKC;	GO:0050853~B cell receptor signaling pathway	35	125	28	0	0	0	0	0	0	0
down	IGHV2-26; IGHV3-53; IGHG3; IGHV3-49; IGHV1-69-2; IGHG4; IGLC7; IGLC3; IGHV3-15; IGHV4-39; IGHV3-21; IGHD; IGHV4-59; IGHV1-69; IGHV3-73; IGLL5; IGHV1-24; IGHA1; IGHV3-72; IGHV3-48; IGHG2; IGHE; IGHV3-20; IGHV1-46; IGHV1-3; IGHV6-1; IGHV3-7; IGHA2; TRDC; IGKC; IGHV3-30; IGHV2-5;	GO:0050871~positive regulation of B cell activation	32	98	32.6530612244898	0	0	0	0	0	0	0
down	KRT86; PPL; CSTA; KRT14; KRT6A; KRT6B; KRT1; KRT18; KRT7; KRT16; KRT10; KRT13; KRT5; JUP; DSP; KRT15; KRT4; FLG; SPRR2D; TGM1; DSG3; KRT9; KRT6C; KRT76; DSG1; DSC2; KRT17; PKP1; DSC3; PRSS8; KAZN; KRT80; SPINK6; RPTN; CERS3; KRT78; EVPL; PERP; TMEM79; KRT23; SPINK5; SPRR3; KLK12; KLK5; PKP3;	GO:0070268~cornification	45	113	39.8230088495575	0	0	0	0	0	0	0
down	CXCR1; FOXC1; ACKR1; CCL26; XCL1; PF4V1; PF4;	GO:0070098~chemokine-mediated signaling pathway	7	70	10	0.00010156802856198	0.00329877025990148	0.260014153118675	0.268139595403634	0.212664181380873	0.260014153118675	0.0278942008944233
down	SLC9A3R1; EGFR; PTPN3; GAS1; FOXC1;	GO:0045930~negative regulation of mitotic cell cycle	5	29	17.2413793103448	0.00010246180352724	0.00329877025990148	0.262199755226215	0.270499161311921	0.213940245764883	0.262199755226215	0.0278942008944233
down	ALOX12B; FA2H; CERS3; SPTSSB; ELOVL1;	GO:0046513~ceramide biosynthetic process	5	31	16.1290322580645	0.00013566906405981	0.00426388487045142	0.347041465865014	0.358166329117919	0.25315847353562	0.346905796800954	0.036055151403789
down	EGFR; ASS1; GJB2; AQP1; EIF4EBP1;	GO:0071549~cellular response to dexamethasone stimulus	5	31	16.1290322580645	0.00013566906405981	0.00426388487045142	0.347041465865014	0.358166329117919	0.25315847353562	0.346905796800954	0.036055151403789
down	LTF; DEFA4; IL36RN;	GO:0019732~antifungal humoral response	3	5	60	0.00014252465063757	0.00432488595038163	0.364150482379008	0.376265077683202	0.260820110666765	0.364007957728371	0.0365709728294378
down	EGFR; DUOXA1; DUOXA2;	GO:0042743~hydrogen peroxide metabolic process	3	5	60	0.00014252465063757	0.00432488595038163	0.364150482379008	0.376265077683202	0.260820110666765	0.364007957728371	0.0365709728294378
down	ALOX15B; ALOX12B; ALOX15; PLA2G3;	GO:0019372~lipoxygenase pathway	4	16	25	0.00015077034730448	0.00451525083761613	0.384916696668351	0.398033716883841	0.268983724526432	0.384916696668351	0.0381806867498979
down	SLC6A15; SLC6A14; SLC6A19; SLC6A11; TMEM184A;	GO:0006810~transport	5	32	15.625	0.00015507821786997	0.00451525083761613	0.395759612004176	0.409406495176734	0.273196574697486	0.395604533786306	0.0381806867498979
down	KRT1; ID1; EMP2; GPNMB; PROK2;	GO:0045765~regulation of angiogenesis	5	32	15.625	0.00015507821786997	0.00451525083761613	0.395759612004176	0.409406495176734	0.273196574697486	0.395604533786306	0.0381806867498979
down	ALDH3B2; FA2H; CERS3; SPTSSB; ELOVL1; ELOVL4;	GO:0030148~sphingolipid biosynthetic process	6	52	11.5384615384615	0.00015563932811479	0.00451525083761613	0.396880286692736	0.410887826223068	0.273705468106248	0.396880286692736	0.0381806867498979
down	SPINT2; MAP7; RHOD; RND3; PARVG; RHOV;	GO:0007163~establishment or maintenance of cell polarity	6	53	11.3207547169811	0.0001712343314818	0.00491368081643445	0.436476310947125	0.452058635111969	0.288016145552399	0.436476310947125	0.0415497864433852
down	EGFR; ADRB2; CLTB; SFN; BTC; VAMP2; DHCR24; EPGN; SLC2A8;	GO:0061024~membrane organization	9	134	6.71641791044776	0.00019000882197517	0.00522524260431728	0.483572451926818	0.501623290014459	0.300973974008675	0.483572451926818	0.0441843339921705
up	PLXNB2; PLXNB1; ATP10A; F2; FN1; TPM1; CCL2; CORO1A; MYH9; CCL7; FGD1; DMTN; FGD6; RHOU; PDPN; BVES; FBLIM1; LPAR1; FERMT2; DLC1; MYO10; PARVA; TAOK2; WASF3; PLXNB3; PLXNA1; RAC3; RHOB; PLXNA3; PLXNA2;	GO:0008360~regulation of cell shape	30	159	18.8679245283019	0.00020091928790588	0.0748256914709509	0.895698185484446	0.897908297651411	0.774625008064669	0.895698185484446	0.672102879515839
down	DSP; GRHL1; PERP;	GO:0002934~desmosome organization	3	6	50	0.00021157223183321	0.00542282225281244	0.538239757783693	0.558550692039681	0.314915779433798	0.536970324392693	0.0458550554955037
down	ALOX15B; ALOX12B; ALOX15;	GO:0034440~lipid oxidation	3	6	50	0.00021157223183321	0.00542282225281244	0.538239757783693	0.558550692039681	0.314915779433798	0.536970324392693	0.0458550554955037
down	ALOX15B; ALOX12B; ALOX15;	GO:0051122~hepoxilin biosynthetic process	3	6	50	0.00021157223183321	0.00542282225281244	0.538239757783693	0.558550692039681	0.314915779433798	0.536970324392693	0.0458550554955037
down	CLDN4; SLC9A3R1; KCNQ1;	GO:0070293~renal absorption	3	6	50	0.00021157223183321	0.00542282225281244	0.538239757783693	0.558550692039681	0.314915779433798	0.536970324392693	0.0458550554955037
down	JUP; DSP; DSC2;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	3	6	50	0.00021157223183321	0.00542282225281244	0.538239757783693	0.558550692039681	0.314915779433798	0.536970324392693	0.0458550554955037
down	DSP; TJP1; CGNL1;	GO:0150105~protein localization to cell-cell junction	3	6	50	0.00021157223183321	0.00542282225281244	0.538239757783693	0.558550692039681	0.314915779433798	0.536970324392693	0.0458550554955037
down	GJB6; GJB2; GJB4;	GO:1990349~gap junction-mediated intercellular transport	3	6	50	0.00021157223183321	0.00542282225281244	0.538239757783693	0.558550692039681	0.314915779433798	0.536970324392693	0.0458550554955037
down	ALOX15B; MT1G; MT1X; PTK6;	GO:0045926~negative regulation of growth	4	18	22.2222222222222	0.00022265721221104	0.00558063234161112	0.564881347379412	0.58781504023715	0.322099729560001	0.564658690167201	0.0471894880183217
down	TSPAN15; DUOXA2; TESC; STUB1;	GO:0051604~protein maturation	4	18	22.2222222222222	0.00022265721221104	0.00558063234161112	0.564881347379412	0.58781504023715	0.322099729560001	0.564658690167201	0.0471894880183217
down	LTF; DEFA4; ROMO1; PGLYRP4; PGLYRP3;	GO:0031640~killing of cells of other organism	5	35	14.2857142857143	0.0002261847199062	0.00558063234161112	0.573378264962238	0.59712766055239	0.324348888345503	0.573152080242332	0.0471894880183217
down	EGFR; PTPN3; BTC; EPGN; CBLC;	GO:0042059~negative regulation of epidermal growth factor receptor signaling pathway	5	35	14.2857142857143	0.0002261847199062	0.00558063234161112	0.573378264962238	0.59712766055239	0.324348888345503	0.573152080242332	0.0471894880183217
down	LTF; RNASE3; DEFB1; DEFA4;	GO:0002227~innate immune response in mucosa	4	19	21.0526315789474	0.00026657203693347	0.00651620534726276	0.675226969552497	0.703750177504379	0.350542228567522	0.675226969552497	0.0551006365115259
down	OVOL1; IRF6; FOXN1; ABLIM3; EGFR; PF4; ADRB2; GATA1; EPCAM; USF1; CDKN2B; PAX9; PITX1; ELF3; HHEX; FOXC1; KLF5; IL18; CEBPE; BATF; ZNF750; MLIP; MACC1; GRHL3; ARNTL2; EHF; GRHL1; POU2F3; BARX2; DLX3; JUP; TBX21;	GO:0045944~positive regulation of transcription by RNA polymerase II	32	1138	2.81195079086116	0.0002841487289853	0.00681956949564722	0.719180433061796	0.750152644521194	0.360584737082347	0.719180433061796	0.0576658653187767
down	PHGDH; SHMT2; PSAT1;	GO:0006564~L-serine biosynthetic process	3	7	42.8571428571429	0.00029911708808794	0.00698822223497491	0.756766232862491	0.789669112552165	0.367914018348168	0.756167998686315	0.0590919826357014
down	RNASE2; RNASE3; SPON2;	GO:0043152~induction of bacterial agglutination	3	7	42.8571428571429	0.00029911708808794	0.00698822223497491	0.756766232862491	0.789669112552165	0.367914018348168	0.756167998686315	0.0590919826357014
down	NUPR1; MMP8; IL18;	GO:0150078~positive regulation of neuroinflammatory response	3	7	42.8571428571429	0.00029911708808794	0.00698822223497491	0.756766232862491	0.789669112552165	0.367914018348168	0.756167998686315	0.0590919826357014
down	CLDN7; EPCAM; DUOXA2; DUOX2;	GO:2000147~positive regulation of cell motility	4	20	20	0.00031637468842649	0.00727618895060394	0.799478837653742	0.835229177445935	0.376169504539097	0.799478837653742	0.0615270116870738
down	EGFR; ELANE; CD24; HTR2A; TPD52L1; EPGN;	GO:0043406~positive regulation of MAP kinase activity	6	60	10	0.00031805144098884	0.00727618895060394	0.803397939937816	0.839655804210544	0.376890957571778	0.803397939937816	0.0615270116870738
down	CLDN1; ARL2; OCLN; POF1B; CRB3;	GO:0070830~bicellular tight junction assembly	5	38	13.1578947368421	0.00031971133267805	0.00727618895060394	0.807271115012081	0.844037918270057	0.377635438445912	0.807271115012081	0.0615270116870738
up	NRP1; LAMA5; LAT; SEMA7A; ITGAV; ITGA2B; ITGA2; ITGB5; ITGA3; CD40LG; MYH9; BCAR1; COL16A1; DOCK1; FERMT3; FERMT2; FERMT1; ADAMTS1; ITGB6; ITGB4; LAMA3;	GO:0007229~integrin-mediated signaling pathway	21	96	21.875	0.00032447998300677	0.111546234158252	1	1	0.92726370277081	0.999997936695675	1
down	CLDN1; EGFR; GYPA; NCAM1; HTR2A; NECTIN4; SLC52A2;	GO:0046718~viral entry into host cell	7	87	8.04597701149425	0.00035278992158671	0.00796038797426436	0.890441762084871	0.93136539298893	0.392081919731744	0.890441762084871	0.067312557061283
down	ATP2C2; MT-CO2; COX8A; SLC15A1; OTOP3; ATP6V1C2; SLC2A8; ATP12A;	GO:1902600~proton transmembrane transport	8	116	6.89655172413793	0.0003619012781626	0.00809677435889211	0.913076924804245	0.955419374349269	0.395919998309886	0.913076924804245	0.0684658320432711
down	CLDN5; CLDN4; CLDN7; CLDN1;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	4	21	19.047619047619	0.0003725037503961	0.00826394874828328	0.939454458498971	0.983409901045711	0.400414585004162	0.939454458498971	0.0698794485229526
down	CCNB1; RRS1; KIF14; CHMP4C; CDCA5;	GO:0007080~mitotic metaphase plate congression	5	40	12.5	0.00039660799117635	0.00872537580587984	0.999848745755595	1	0.410489270867529	0.954206509292319	0.0737812476870767
down	AQP1; SCNN1A; SCNN1B;	GO:0050891~multicellular organismal water homeostasis	3	8	37.5	0.0004070312003952	0.00880788827084701	1	1	0.414519172895785	0.954206509292319	0.0744789680776312
down	LTF; RNASE7; DEFA4;	GO:0051673~membrane disruption in other organism	3	8	37.5	0.0004070312003952	0.00880788827084701	1	1	0.414519172895785	0.954206509292319	0.0744789680776312
down	LILRA5; ORM1; MMP8; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	4	22	18.1818181818182	0.00043540342293169	0.00934524419950946	1	1	0.423945368886216	0.954206509292319	0.0790228171622799
down	CD8B; ERBB3; BDKRB2; EGFR; PTK6; FGFR3; EPHB3; ROR2;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	8	120	6.66666666666667	0.00044780006035538	0.00953380773659853	1	1	0.427850448433288	0.954206509292319	0.080617298975355
down	MYO1B; EMP2; CGNL1; POF1B; MAD2L2; RND3; RHOV; RHOD;	GO:0007015~actin filament organization	8	121	6.61157024793388	0.000471671806753	0.00996170855862346	1	1	0.435365614352991	0.954206509292319	0.084235602328438
down	CXCL14; RNASE2; DEFB1; CMTM2; CMTM5; PROK2; CCL26; CXCR1;	GO:0006935~chemotaxis	8	122	6.55737704918033	0.00049656471933667	0.0104042131670542	1	1	0.443432294367654	0.954206509292319	0.0879773944120869
down	EGFR; ROR2; NLGN1; TNR;	GO:0051968~positive regulation of synaptic transmission, glutamatergic	4	23	17.3913043478261	0.00050552264179026	0.0104264044869243	1	1	0.446238496550314	0.954206509292319	0.0881650428646307
down	AKR7A2; AKR1B10; AKR1C2;	GO:0044597~daunorubicin metabolic process	3	9	33.3333333333333	0.00053709783844824	0.0107422286729175	1	1	0.456207132997318	0.954206509292319	0.0908356329928672
down	AKR7A2; AKR1B10; AKR1C2;	GO:0044598~doxorubicin metabolic process	3	9	33.3333333333333	0.00053709783844824	0.0107422286729175	1	1	0.456207132997318	0.954206509292319	0.0908356329928672
down	IGHD; ORM1; SAA1;	GO:0050716~positive regulation of interleukin-1 secretion	3	9	33.3333333333333	0.00053709783844824	0.0107422286729175	1	1	0.456207132997318	0.954206509292319	0.0908356329928672
down	RHOD; GIPC1; NLGN1; AP1S3; HAP1;	GO:0006605~protein targeting	5	43	11.6279069767442	0.00053711143364587	0.0107422286729175	1	1	0.456207132997318	0.954206509292319	0.0908356329928672
down	CLDN1; ASS1; TCL1A; LCN2; OCLN; NPNT; CCL26; XCL1;	GO:0071356~cellular response to tumor necrosis factor	8	125	6.4	0.00057769571415045	0.0114070339294712	1	1	0.469088919890166	0.954206509292319	0.0964571858507281
down	AOC1; GJB2; ID1; AOC3;	GO:0046677~response to antibiotic	4	24	16.6666666666667	0.00058331423502977	0.0114070339294712	1	1	0.470836430640324	0.954206509292319	0.0964571858507281
down	BDKRB2; PLA2G4F; PLA2G3; ANXA1;	GO:0050482~arachidonic acid secretion	4	24	16.6666666666667	0.00058331423502977	0.0114070339294712	1	1	0.470836430640324	0.954206509292319	0.0964571858507281
down	SULT2B1; CYP2E1; SULT1E1; AKR1C2; DHCR24;	GO:0008202~steroid metabolic process	5	44	11.3636363636364	0.00059135360796291	0.0114792170957508	1	1	0.473522002188316	0.954206509292319	0.0970675623191578
down	SLC9A3R1; ANXA1; S100B; EPB42; CDC42EP1; PALMD; RHOV; RND3; RHOD;	GO:0008360~regulation of cell shape	9	159	5.66037735849057	0.00062044717875331	0.0119560624226916	1	1	0.480846563533818	0.954206509292319	0.10109973743209
up	NRP1; TBX1; HS6ST1; FGF18; FN1; PDGFA; SERPINE1; JUN; ITGAV; MMP2; COL4A2; CCL2; SHC1; MYH9; MCAM; MMP14; VAV2; EPHB4; RHOB; JAG1; HSPG2; CAV1; MFGE8; DAB2IP; CSPG4; ADM2; PLCD3; NRCAM; ANGPTL4; POFUT1; TNFRSF12A; ESM1; EGFL7; APLN; AMOTL1; PGF; VEGFC;	GO:0001525~angiogenesis	37	230	16.0869565217391	0.00063391617827679	0.162193505657058	1	1	0.999997936695675	0.999997936695675	1
down	RHOD; MYO1B; AIF1L; RND3; PLS3;	GO:0051017~actin filament bundle assembly	5	45	11.1111111111111	0.00064959995787705	0.0122495992056816	1	1	0.487199968407792	0.954206509292319	0.103581866634646
down	S100B; VAMP2; NLGN1; TNR; GRIN2D;	GO:0060291~long-term synaptic potentiation	5	45	11.1111111111111	0.00064959995787705	0.0122495992056816	1	1	0.487199968407792	0.954206509292319	0.103581866634646
down	CCNB1; KLF5; IL18; PLA2G4F; P2RY13;	GO:0071407~cellular response to organic cyclic compound	5	45	11.1111111111111	0.00064959995787705	0.0122495992056816	1	1	0.487199968407792	0.954206509292319	0.103581866634646
up	TBX3; IFNG; CCND1; SOX9; CAV1; SMO;	GO:0030857~negative regulation of epithelial cell differentiation	6	9	66.6666666666667	0.00065327435708817	0.162193505657058	1	1	0.999997936695675	0.999997936695675	1
down	OVOL1; USP2; DKK1; ELANE; NR2F6; TXN; GATA1; IFI27; HHEX; FOXC1; KLF5; TRIM29; MLIP; WWC1; SDR16C5; TRIB3; FOXQ1; CBX8; MAD2L2; TBX21; NOTCH3; BARX2; ID1; HES6; HES2;	GO:0000122~negative regulation of transcription by RNA polymerase II	25	847	2.95159386068477	0.0006544232699962	0.0122530314382269	1	1	0.488199759417171	0.954206509292319	0.103610889384517
down	MUC1; HHEX; MAD2L2;	GO:0010944~negative regulation of transcription by competitive promoter binding	3	10	30	0.00069101411829986	0.0126685921688308	1	1	0.495318087130175	0.954206509292319	0.10712484567429
down	PSEN2; DHCR24; PSENEN;	GO:0042987~amyloid precursor protein catabolic process	3	10	30	0.00069101411829986	0.0126685921688308	1	1	0.495318087130175	0.954206509292319	0.10712484567429
down	GSDMD; GSDMA; GSDMC;	GO:0070269~pyroptosis	3	10	30	0.00069101411829986	0.0126685921688308	1	1	0.495318087130175	0.954206509292319	0.10712484567429
down	PTGES; DKK1; LRAT; IGFBP2; GJB2;	GO:0032526~response to retinoic acid	5	46	10.8695652173913	0.00071203506315731	0.0129639487361056	1	1	0.499275344604858	0.954206509292319	0.109622362862194
down	PLA2G4E; PLA2G4F; PLA2G4D; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	4	26	15.3846153846154	0.00076374050855554	0.0138101023464838	1	1	0.509414919206548	0.954206509292319	0.116777386381818
down	HSPB1; GSTP1; SFN; CAMK2N1; TESC; TRIB3;	GO:0006469~negative regulation of protein kinase activity	6	72	8.33333333333333	0.00078124186414108	0.0140304661315133	1	1	0.512685575658375	0.954206509292319	0.118640769159391
down	RHOD; SAA1; AZU1; FUT7; EPB41L4B;	GO:0045785~positive regulation of cell adhesion	5	48	10.4166666666667	0.00085022332482975	0.0149210314286906	1	1	0.526221319462667	0.954206509292319	0.126171335204268
down	ALOX15B; ALOX12B; ALOX15; MGLL;	GO:0019369~arachidonic acid metabolic process	4	27	14.8148148148148	0.00086729321537304	0.0149210314286906	1	1	0.529385297441406	0.954206509292319	0.126171335204268
down	ANXA1; HSPB1; MT1G; GAS1;	GO:0035924~cellular response to vascular endothelial growth factor stimulus	4	27	14.8148148148148	0.00086729321537304	0.0149210314286906	1	1	0.529385297441406	0.954206509292319	0.126171335204268
up	MYO1C; SNAI2; ACTN4; MAP4K4; PLAU; PDGFB; PDGFA; ITGAV; LAMB1; IGF1R; F3; MDK; CORO1A; MCAM; NOTCH1; CD151; MMP14; CDH13; BCAR1; CCL7; CAV1; LAMC2; TRIP6; PLET1; FAM83H; FERMT3; PDPN; TWIST2; SMO; ZNF703; SPHK1; PDGFC; SEMA6D; SEMA3F; SEMA3C; SEMA7A;	GO:0030335~positive regulation of cell migration	36	226	15.929203539823	0.00086888381918282	0.193331103479277	1	1	0.999997936695675	0.999997936695675	1
down	EFNA5; EPHB3; FUT7;	GO:0022407~regulation of cell-cell adhesion	3	11	27.2727272727273	0.00087039350000695	0.0149210314286906	1	1	0.530069641504232	0.954206509292319	0.126171335204268
down	FUT3; FUT2; FUT7;	GO:0036065~fucosylation	3	11	27.2727272727273	0.00087039350000695	0.0149210314286906	1	1	0.530069641504232	0.954206509292319	0.126171335204268
down	IRF6; KLK8; SDR16C5;	GO:0043616~keratinocyte proliferation	3	11	27.2727272727273	0.00087039350000695	0.0149210314286906	1	1	0.530069641504232	0.954206509292319	0.126171335204268
down	JUP; DSP; DSC2;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	3	11	27.2727272727273	0.00087039350000695	0.0149210314286906	1	1	0.530069641504232	0.954206509292319	0.126171335204268
up	PDLIM1; PAK4; CDH2; SHC1; SOX9; SCRIB; FAT1; CNN3; NLGN2; DLG5; FBLIM1; NRCAM; ROPN1B; TENM2; BAIAP2L1; CDH11; LAMA3; ARVCF; CELSR1; CDH13; CDH3; FAT2; FAT4; COL16A1; DSG2; LAMA5; ICOS;	GO:0098609~cell-cell adhesion	27	152	17.7631578947368	0.00090847016627093	0.193331103479277	1	1	0.999997936695675	0.999997936695675	1
down	BANF1; HSPB1; CFL1; XCL1; LCN2; DUOX2; TBX21;	GO:0009615~response to virus	7	104	6.73076923076923	0.00095599814449076	0.0162828071061653	1	1	0.545874940504227	0.954206509292319	0.137686427595623
down	EGFR; BTC; GRB7; FAM83B; EPGN;	GO:0007173~epidermal growth factor receptor signaling pathway	5	50	10	0.00100744687548793	0.0170491009697957	1	1	0.553449698926374	0.954206509292319	0.144166161948784
down	SAA1; XCL1; CXCR1; PF4; CCL26; PF4V1;	GO:0030593~neutrophil chemotaxis	6	76	7.89473684210526	0.00101642600910723	0.0170914946754337	1	1	0.554946465585873	0.954206509292319	0.144524640547945
down	ADH7; ALDH3B2; SULT1E1;	GO:0006068~ethanol catabolic process	3	12	25	0.00107676822655911	0.0175477372842209	1	1	0.563747931235217	0.954206509292319	0.148382600327929
down	HTR2A; PTGDR; IL18;	GO:0030431~sleep	3	12	25	0.00107676822655911	0.0175477372842209	1	1	0.563747931235217	0.954206509292319	0.148382600327929
down	CFL1; EPS8L1; RHOD; CDC42EP1; RHOV; RND3;	GO:0007266~Rho protein signal transduction	6	77	7.79220779220779	0.00108291091171031	0.0175477372842209	1	1	0.564599409924677	0.954206509292319	0.148382600327929
down	DKK1; SLPI; ID1; CARD18; CTNNBIP1; STUB1;	GO:0032091~negative regulation of protein binding	6	77	7.79220779220779	0.00108291091171031	0.0175477372842209	1	1	0.564599409924677	0.954206509292319	0.148382600327929
down	EFNA5; ARHGEF19; GRHL3; RND3; RHOD; RHOV;	GO:0032956~regulation of actin cytoskeleton organization	6	77	7.79220779220779	0.00108291091171031	0.0175477372842209	1	1	0.564599409924677	0.954206509292319	0.148382600327929
down	ORM1; BPI; NLRX1; IL36RN;	GO:0032715~negative regulation of interleukin-6 production	4	29	13.7931034482759	0.00110338045044722	0.0175477372842209	1	1	0.567652668658544	0.954206509292319	0.148382600327929
down	PRMT5; EGFR; GSTP1; FAM83D;	GO:0070372~regulation of ERK1 and ERK2 cascade	4	29	13.7931034482759	0.00110338045044722	0.0175477372842209	1	1	0.567652668658544	0.954206509292319	0.148382600327929
down	MT1G; AOC1; AQP1; MT1X;	GO:0071280~cellular response to copper ion	4	29	13.7931034482759	0.00110338045044722	0.0175477372842209	1	1	0.567652668658544	0.954206509292319	0.148382600327929
down	ANXA1; ALOX15; XCL1; DUOXA1; DUOXA2; MGLL;	GO:0050727~regulation of inflammatory response	6	78	7.69230769230769	0.00115267925110074	0.0179004307229762	1	1	0.574034267048169	0.954206509292319	0.151364954617458
down	LILRA5; MAPK13; EGFR; IL18; NLRP10; MGST2;	GO:0050729~positive regulation of inflammatory response	6	78	7.69230769230769	0.00115267925110074	0.0179004307229762	1	1	0.574034267048169	0.954206509292319	0.151364954617458
down	LILRA5; ALOX12B; ADRB2; FGFR3; MMP8; WWC1; ROR2;	GO:0043410~positive regulation of MAPK cascade	7	109	6.42201834862385	0.00123675494510467	0.018983998562914	1	1	0.583882459358238	0.954206509292319	0.160527538437667
down	TXN; NME1; MMP8; FOXC1;	GO:0043388~positive regulation of DNA binding	4	30	13.3333333333333	0.00123683627000803	0.018983998562914	1	1	0.583882459358238	0.954206509292319	0.160527538437667
down	CA2; HAP1; NLGN1;	GO:0032230~positive regulation of synaptic transmission, GABAergic	3	13	23.0769230769231	0.0013115917047668	0.0200150410438402	1	1	0.592839450554594	0.954206509292319	0.169245971013356
down	VGLL3; FOXN1; EGFR; USF1; CKS2; ECM1; OLIG1; ARNTL2; VGLL1; POU2F3; BATF; NR2F6; FOXC1; GRHL3; KLF5; GRHL1; HOPX; DLX3; FOXQ1; EHF; ELF3; BARX2;	GO:0006357~regulation of transcription by RNA polymerase II	22	747	2.94511378848728	0.00137603706298906	0.0207176959881905	1	1	0.60051224419137	0.954206509292319	0.175187578531593
down	CA2; ASS1; KRT14; GGH;	GO:0010043~response to zinc ion	4	31	12.9032258064516	0.00138117973254603	0.0207176959881905	1	1	0.600930414510212	0.954206509292319	0.175187578531593
down	PRMT5; CLDN1; EGFR; PTPN3;	GO:0097421~liver regeneration	4	31	12.9032258064516	0.00138117973254603	0.0207176959881905	1	1	0.600930414510212	0.954206509292319	0.175187578531593
up	COL4A1; COL4A5; DDR1; DDR2; COL4A6; COL4A2;	GO:0038063~collagen-activated tyrosine kinase receptor signaling pathway	6	11	54.5454545454545	0.00140703625902683	0.241847886215034	1	1	0.999997936695675	0.999997936695675	1
up	PLXNA2; SOX9; WNT3; SOX4; SEMA3C; ZNF219;	GO:0060174~limb bud formation	6	11	54.5454545454545	0.00140703625902683	0.241847886215034	1	1	0.999997936695675	0.999997936695675	1
up	PRSS23; FSTL3; F2; SERPINA1; CALCA; APOA2; FN1; APP; LAMB1; MMP2; MELTF; LGALS1; UBB; LAMC1; F5; CDH2; TNC; SNCA; LAMB2; HSPG2; CKAP4; MFGE8; FSTL1; GAS6; TMEM132A; TSPAN33; FAM20C; PCSK9; SCG3; EVA1A; NAT8; ZDHHC2;	GO:0044267~cellular protein metabolic process	32	200	16	0.00152282237205259	0.247761700684282	1	1	0.999997936695675	0.999997936695675	1
down	HBD; HBA1; HBM;	GO:0015671~oxygen transport	3	14	21.4285714285714	0.00157624083023711	0.0229904739879888	1	1	0.617886405452946	0.954206509292319	0.19440605121077
down	CD24; PPP1R14C; PPP1R14A;	GO:0042325~regulation of phosphorylation	3	14	21.4285714285714	0.00157624083023711	0.0229904739879888	1	1	0.617886405452946	0.954206509292319	0.19440605121077
down	SAA1; AZU1; CXCL17;	GO:0048246~macrophage chemotaxis	3	14	21.4285714285714	0.00157624083023711	0.0229904739879888	1	1	0.617886405452946	0.954206509292319	0.19440605121077
down	SCNN1A; SCNN1B; SLC12A1;	GO:0055078~sodium ion homeostasis	3	14	21.4285714285714	0.00157624083023711	0.0229904739879888	1	1	0.617886405452946	0.954206509292319	0.19440605121077
down	CLDN5; TJP1; OCLN;	GO:2000810~regulation of bicellular tight junction assembly	3	14	21.4285714285714	0.00157624083023711	0.0229904739879888	1	1	0.617886405452946	0.954206509292319	0.19440605121077
up	ARHGAP6; ITGA2; CTTN; PTPRK; TRIP6; FERMT2; AJUBA; DLC1; TAOK2;	GO:0048041~focal adhesion assembly	9	27	33.3333333333333	0.00158497256269308	0.247761700684282	1	1	0.999997936695675	0.999997936695675	1
down	PPL; SCEL; CCNB1; IGFBP2; RETN;	GO:0009612~response to mechanical stimulus	5	57	8.7719298245614	0.0017305034451256	0.024683114368737	1	1	0.631094509007264	0.954206509292319	0.208718915430667
down	EGFR; NME1; ID1; EPGN; ESRP2;	GO:0050679~positive regulation of epithelial cell proliferation	5	57	8.7719298245614	0.0017305034451256	0.024683114368737	1	1	0.631094509007264	0.954206509292319	0.208718915430667
down	SAA1; CD24; BDKRB2; NMU; BCAP31; PROK2; PTGDR; CXCR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	8	150	5.33333333333333	0.00175528048846774	0.024683114368737	1	1	0.633257363414223	0.954206509292319	0.208718915430667
down	SCD5; ELOVL1; ELOVL4;	GO:0006636~unsaturated fatty acid biosynthetic process	3	15	20	0.00187201825674943	0.024683114368737	1	1	0.643197691371787	0.954206509292319	0.208718915430667
down	GGT6; MGST2; CHAC1;	GO:0006750~glutathione biosynthetic process	3	15	20	0.00187201825674943	0.024683114368737	1	1	0.643197691371787	0.954206509292319	0.208718915430667
down	SLC6A19; SLC6A15; SLC6A14;	GO:0006836~neurotransmitter transport	3	15	20	0.00187201825674943	0.024683114368737	1	1	0.643197691371787	0.954206509292319	0.208718915430667
down	XCL1; IL20RB; TBX21;	GO:0032703~negative regulation of interleukin-2 production	3	15	20	0.00187201825674943	0.024683114368737	1	1	0.643197691371787	0.954206509292319	0.208718915430667
down	PLA2G4D; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	3	15	20	0.00187201825674943	0.024683114368737	1	1	0.643197691371787	0.954206509292319	0.208718915430667
down	KRT1; KRT10; FARSA;	GO:0051290~protein heterotetramerization	3	15	20	0.00187201825674943	0.024683114368737	1	1	0.643197691371787	0.954206509292319	0.208718915430667
down	OVOL1; KRT9; DHCR24; DSP;	GO:0043588~skin development	4	34	11.7647058823529	0.00188410176400267	0.024683114368737	1	1	0.644362803288912	0.954206509292319	0.208718915430667
down	DKK1; EGFR; S100B; GM2A; PTPRZ1;	GO:0007611~learning or memory	5	59	8.47457627118644	0.0019931723662816	0.025921059344746	1	1	0.653760536140366	0.954206509292319	0.219186902934007
down	KLK8; HTR2A; EMP1; EMP2;	GO:0008219~cell death	4	35	11.4285714285714	0.00207654853505645	0.0266120783133449	1	1	0.65932295472945	0.954206509292319	0.225030117348256
down	LILRA5; ORM1; GSDMD; LILRA2;	GO:0050718~positive regulation of interleukin-1 beta secretion	4	35	11.4285714285714	0.00207654853505645	0.0266120783133449	1	1	0.65932295472945	0.954206509292319	0.225030117348256
down	SLC9A3R1; NUPR1; BCAP31; BOK;	GO:2001244~positive regulation of intrinsic apoptotic signaling pathway	4	35	11.4285714285714	0.00207654853505645	0.0266120783133449	1	1	0.65932295472945	0.954206509292319	0.225030117348256
down	CTSV; S100B; ANXA3; IGFBP2; ALDH3A1;	GO:0051384~response to glucocorticoid	5	60	8.33333333333333	0.00213489092814367	0.0272275944458903	1	1	0.662936732637972	0.954206509292319	0.230234884368162
down	CLDN5; PF4; EFNA3; HHEX; FOXC1; SPINK5;	GO:0016525~negative regulation of angiogenesis	6	89	6.74157303370786	0.00216810817542745	0.0272695219468345	1	1	0.665094463587434	0.954206509292319	0.230589420768758
down	HRH2; RAB25; POF1B;	GO:0003382~epithelial cell morphogenesis	3	16	18.75	0.0022001546116196	0.0272695219468345	1	1	0.666759572078392	0.954206509292319	0.230589420768758
down	ASTN1; NLGN1; TNR;	GO:0007158~neuron cell-cell adhesion	3	16	18.75	0.0022001546116196	0.0272695219468345	1	1	0.666759572078392	0.954206509292319	0.230589420768758
down	CSTA; CSTB; ECM1;	GO:0010466~negative regulation of peptidase activity	3	16	18.75	0.0022001546116196	0.0272695219468345	1	1	0.666759572078392	0.954206509292319	0.230589420768758
down	FCGR2B; MNDA; CD300A;	GO:0030889~negative regulation of B cell proliferation	3	16	18.75	0.0022001546116196	0.0272695219468345	1	1	0.666759572078392	0.954206509292319	0.230589420768758
down	AQP1; RHOD; RND3;	GO:0030950~establishment or maintenance of actin cytoskeleton polarity	3	16	18.75	0.0022001546116196	0.0272695219468345	1	1	0.666759572078392	0.954206509292319	0.230589420768758
down	FUT3; FUT2; FUT7; ST6GALNAC5; B3GNT3; B3GNT8;	GO:0006486~protein glycosylation	6	90	6.66666666666667	0.00228590742457102	0.0281999794433061	1	1	0.67205678282388	0.954206509292319	0.238457312827138
down	SLC9A3R1; ABLIM3; CFL1; RND3; POF1B; AMOTL2; RHOV; ARHGEF10L;	GO:0030036~actin cytoskeleton organization	8	157	5.09554140127389	0.00230053320092016	0.028248407676415	1	1	0.673234993987675	0.954206509292319	0.238866819023955
down	EPCAM; SDC4; FOXC1; NPNT;	GO:0001657~ureteric bud development	4	37	10.8108108108108	0.00250133145160347	0.0300159774192417	1	1	0.685364817739351	0.954206509292319	0.253813281377106
down	FOXN1; DKK1; EGFR; APCDD1;	GO:0001942~hair follicle development	4	37	10.8108108108108	0.00250133145160347	0.0300159774192417	1	1	0.685364817739351	0.954206509292319	0.253813281377106
down	ASS1; ORM1; SAA1; SAA2;	GO:0006953~acute-phase response	4	37	10.8108108108108	0.00250133145160347	0.0300159774192417	1	1	0.685364817739351	0.954206509292319	0.253813281377106
down	ALOX15; ARL2; NPNT; FBLN2;	GO:0010811~positive regulation of cell-substrate adhesion	4	37	10.8108108108108	0.00250133145160347	0.0300159774192417	1	1	0.685364817739351	0.954206509292319	0.253813281377106
down	CLDN7; CRYAB; EIF4EBP1; CTNNBIP1;	GO:0031333~negative regulation of protein-containing complex assembly	4	37	10.8108108108108	0.00250133145160347	0.0300159774192417	1	1	0.685364817739351	0.954206509292319	0.253813281377106
down	ALOX15B; PF4; IL18;	GO:0010744~positive regulation of macrophage derived foam cell differentiation	3	17	17.6470588235294	0.00256181065825278	0.0304647753954385	1	1	0.689127067069999	0.954206509292319	0.257608289796218
down	CTSV; GRHL1; SERPINB13;	GO:0045616~regulation of keratinocyte differentiation	3	17	17.6470588235294	0.00256181065825278	0.0304647753954385	1	1	0.689127067069999	0.954206509292319	0.257608289796218
down	AKR1B10; LRAT; SDC4; ADH7; RDH12;	GO:0001523~retinoid metabolic process	5	63	7.93650793650794	0.00260410611590833	0.0308288795784664	1	1	0.692089898958821	0.954206509292319	0.260687132646033
down	KRT1; ELANE; SAA1; CXCL17; NLRX1; PBK;	GO:0050728~negative regulation of inflammatory response	6	93	6.45161290322581	0.00266830507190252	0.0311104071231082	1	1	0.696143019234584	0.954206509292319	0.263067712458763
up	WNT5A; PTK7; SFRP1; CELSR1; VANGL2; DVL1;	GO:0090179~planar cell polarity pathway involved in neural tube closure	6	13	46.1538461538462	0.00268816691111329	0.387529610508557	1	1	0.999997936695675	0.999997936695675	1
down	JUP; DSP; KCNQ1; DSC2;	GO:0086091~regulation of heart rate by cardiac conduction	4	38	10.5263157894737	0.00273454652257998	0.0311104071231082	1	1	0.700043909780476	0.954206509292319	0.263067712458763
down	MPZL2; KRT18; CST6; PHLDA3; FOXQ1; FOXC1; PITX1;	GO:0009653~anatomical structure morphogenesis	7	127	5.51181102362205	0.00281272051345138	0.0311999250231582	1	1	0.704892612210834	0.954206509292319	0.263824670382748
down	PF4; JUP; FUT3; ERBB3; PLCD1; FA2H; ANXA1; PTK6;	GO:0042127~regulation of cell population proliferation	8	163	4.9079754601227	0.0028664549706674	0.0316629335672047	1	1	0.708014377754847	0.954206509292319	0.267739842500207
down	CES2; PTGES; AKR1C2;	GO:0006693~prostaglandin metabolic process	3	18	16.6666666666667	0.00295807940689086	0.0321349628010832	1	1	0.713598457222203	0.954206509292319	0.271731293022815
down	PLA2G4F; PLA2G4D; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	3	18	16.6666666666667	0.00295807940689086	0.0321349628010832	1	1	0.713598457222203	0.954206509292319	0.271731293022815
down	DSP; KRT9; KRT17;	GO:0045109~intermediate filament organization	3	18	16.6666666666667	0.00295807940689086	0.0321349628010832	1	1	0.713598457222203	0.954206509292319	0.271731293022815
down	NPNT; PROK2; NMU;	GO:0045987~positive regulation of smooth muscle contraction	3	18	16.6666666666667	0.00295807940689086	0.0321349628010832	1	1	0.713598457222203	0.954206509292319	0.271731293022815
down	GSTP1; UCHL1; CD300A; CBLC;	GO:0043407~negative regulation of MAP kinase activity	4	39	10.2564102564103	0.00298222192661568	0.0321349628010832	1	1	0.715652645370953	0.954206509292319	0.271731293022815
down	LILRA5; ERBB3; CD24; DOK7;	GO:0061098~positive regulation of protein tyrosine kinase activity	4	39	10.2564102564103	0.00298222192661568	0.0321349628010832	1	1	0.715652645370953	0.954206509292319	0.271731293022815
down	ALOX15B; ALOX15; ALDH3B2; FABP5; MGLL; MGST2; EPHX3;	GO:0006629~lipid metabolic process	7	130	5.38461538461539	0.00318110752513145	0.0341387149038498	1	1	0.725303916085931	0.954206509292319	0.288674899061892
down	MAPK13; AQP1; LCN2; CBX8; ANXA1;	GO:0070301~cellular response to hydrogen peroxide	5	67	7.46268656716418	0.00334041804743879	0.0355592888920903	1	1	0.730331322449596	0.954206509292319	0.300687186396675
down	SLC9A3R1; PSCA; GSTP1; CAMK2N1; NDRG2;	GO:0070373~negative regulation of ERK1 and ERK2 cascade	5	67	7.46268656716418	0.00334041804743879	0.0355592888920903	1	1	0.730331322449596	0.954206509292319	0.300687186396675
up	PXDN; MEGF9; LAMB2; LAMB3; LAMB1;	GO:0070831~basement membrane assembly	5	9	55.5555555555556	0.00337045429696514	0.454821854528242	1	1	0.999997936695675	0.999997936695675	1
down	MAPK13; EGFR; MAP7;	GO:0006970~response to osmotic stress	3	19	15.7894736842105	0.00338998817448544	0.0356556525125161	1	1	0.731944957717934	0.954206509292319	0.301502031316234
down	PLA2G4E; PLA2G4F; PLA2G4D;	GO:0036149~phosphatidylinositol acyl-chain remodeling	3	19	15.7894736842105	0.00338998817448544	0.0356556525125161	1	1	0.731944957717934	0.954206509292319	0.301502031316234
down	FOLR2; SHMT2; FPGS;	GO:0046655~folic acid metabolic process	3	19	15.7894736842105	0.00338998817448544	0.0356556525125161	1	1	0.731944957717934	0.954206509292319	0.301502031316234
up	NRP1; WNT5A; PLXNA3; WNT3; SEMA3F; SEMA6D; SEMA7A; SEMA3C;	GO:0048843~negative regulation of axon extension involved in axon guidance	8	25	32	0.00351244167898512	0.454821854528242	1	1	0.999997936695675	0.999997936695675	1
up	ADCY6; OXT; SLC4A1; AVPR2;	GO:0035811~negative regulation of urine volume	4	5	80	0.00356204182333597	0.454821854528242	1	1	0.999997936695675	0.999997936695675	1
down	S100B; GSTP1; PTPRZ1; GRHL3; KLK6; SPINK5; SPINK6;	GO:0007417~central nervous system development	7	133	5.26315789473684	0.00358522582699627	0.0374110521077872	1	1	0.737721038508006	0.954206509292319	0.316345583641076
down	FGFR3; PTK6; IL18; STAP2; ARL2BP;	GO:0042531~positive regulation of tyrosine phosphorylation of STAT protein	5	69	7.2463768115942	0.00375981861927865	0.0383047993733565	1	1	0.742836995779213	0.954206509292319	0.323903056217349
down	NUPR1; ID1; XCL1; CTNNBIP1; MAD2L2;	GO:0043433~negative regulation of DNA-binding transcription factor activity	5	69	7.2463768115942	0.00375981861927865	0.0383047993733565	1	1	0.742836995779213	0.954206509292319	0.323903056217349
down	CA2; CA4; AQP1; HBA1;	GO:0015701~bicarbonate transport	4	42	9.52380952380952	0.00381624963527893	0.0383047993733565	1	1	0.74419303264628	0.954206509292319	0.323903056217349
down	TSPAN15; EGFR; CHAC1; NOTCH3;	GO:0045746~negative regulation of Notch signaling pathway	4	42	9.52380952380952	0.00381624963527893	0.0383047993733565	1	1	0.74419303264628	0.954206509292319	0.323903056217349
down	CTDSPL; CDK2AP2; CDKN2B; GPNMB;	GO:2000134~negative regulation of G1/S transition of mitotic cell cycle	4	42	9.52380952380952	0.00381624963527893	0.0383047993733565	1	1	0.74419303264628	0.954206509292319	0.323903056217349
down	MT-CO2; COX8A; COX5B;	GO:0006123~mitochondrial electron transport, cytochrome c to oxygen	3	20	15	0.00385850059510595	0.0383047993733565	1	1	0.745418161067601	0.954206509292319	0.323903056217349
down	CKB; MAOB; DYNLL1; NDRG2;	GO:0021762~substantia nigra development	4	43	9.30232558139535	0.00412597595289887	0.0403428759839001	1	1	0.752417622426368	0.954206509292319	0.341136908208735
down	JUP; DSP; NECTIN4; CDH26;	GO:0034332~adherens junction organization	4	43	9.30232558139535	0.00412597595289887	0.0403428759839001	1	1	0.752417622426368	0.954206509292319	0.341136908208735
down	EGFR; GSTP1; ID1; FOXC1;	GO:0071364~cellular response to epidermal growth factor stimulus	4	43	9.30232558139535	0.00412597595289887	0.0403428759839001	1	1	0.752417622426368	0.954206509292319	0.341136908208735
down	RAMP1; PF4; ADGRF1; ADGRG6; ADGRE3; PTGDR;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	6	103	5.8252427184466	0.00429400020145987	0.0416770607788752	1	1	0.756665338892134	0.954206509292319	0.352418693774012
down	ASS1; CRYAB; GSTP1; IGFBP2; GJB2; ANXA1;	GO:0032355~response to estradiol	6	103	5.8252427184466	0.00429400020145987	0.0416770607788752	1	1	0.756665338892134	0.954206509292319	0.352418693774012
down	PLA2G4E; PLA2G4F; PLA2G4D;	GO:0036150~phosphatidylserine acyl-chain remodeling	3	21	14.2857142857143	0.004364518581775	0.04189937838504	1	1	0.758918350666206	0.954206509292319	0.354298597944396
down	CLDN1; TJP1; OCLN;	GO:0045216~cell-cell junction organization	3	21	14.2857142857143	0.004364518581775	0.04189937838504	1	1	0.758918350666206	0.954206509292319	0.354298597944396
down	CPE; RAB38; HPS6;	GO:0072657~protein localization to membrane	3	21	14.2857142857143	0.004364518581775	0.04189937838504	1	1	0.758918350666206	0.954206509292319	0.354298597944396
down	ANXA1; FOLR2; CCL26; XCL1;	GO:0002548~monocyte chemotaxis	4	44	9.09090909090909	0.00445223636391168	0.0424328664286167	1	1	0.761264590513688	0.954206509292319	0.358809740427761
down	ALOX15; FGFR3; ROR2; GPNMB;	GO:0030282~bone mineralization	4	44	9.09090909090909	0.00445223636391168	0.0424328664286167	1	1	0.761264590513688	0.954206509292319	0.358809740427761
down	MACROD2; GRIN2D; PHGDH; CD9; ID1; SLC6A11; HAP1; FPGS; BOK;	GO:0007420~brain development	9	217	4.14746543778802	0.00468510852781612	0.0444916781058797	1	1	0.767135857378401	0.954206509292319	0.376218926883526
down	EPHB3; ROR2; EGFR; ERBB3; FGFR3;	GO:0033674~positive regulation of kinase activity	5	73	6.84931506849315	0.00470952670037827	0.0445632634014288	1	1	0.767652852161659	0.954206509292319	0.376824247793384
up	PLXNB2; CLSTN1; CDH13; DSG2; FAT1; SDK2; FAT4; CELSR1; FAT2; TENM3; CD84; PLXNB3; PCDHGC3; PCDHGB4; IGSF9B; PCDHB2; PCDHGC5; PCDHGB2; ROBO1; BSG; MYOT; PALLD; L1CAM; CDH11; CDH3; CDH2;	GO:0007156~homophilic cell adhesion via plasma membrane adhesion molecules	26	165	15.7575757575758	0.00473356040594053	0.587618929281895	1	1	0.999997936695675	0.999997936695675	1
down	CDH16; DSG1; NLGN1; CDH26;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	4	45	8.88888888888889	0.00479542594221105	0.0452140160265613	1	1	0.769838504030411	0.954206509292319	0.382326972453743
down	CCNB1; ADAM15; KLK6;	GO:0042246~tissue regeneration	3	22	13.6363636363636	0.0049088842406505	0.0459555120401324	1	1	0.772663998257513	0.954206509292319	0.388597017693444
down	CSTA; CSTB; CAMK2N1;	GO:0045861~negative regulation of proteolysis	3	22	13.6363636363636	0.0049088842406505	0.0459555120401324	1	1	0.772663998257513	0.954206509292319	0.388597017693444
down	CXCL14; AZU1; SAA2; SAA1; CXCR1;	GO:0060326~cell chemotaxis	5	74	6.75675675675676	0.00497127654665408	0.0461129245201108	1	1	0.774620109645507	0.954206509292319	0.389928088060235
down	GJB6; CXCL14; GJB2; KCNQ1;	GO:0048839~inner ear development	4	46	8.69565217391304	0.00515593254944458	0.0462981698317472	1	1	0.77871862874416	0.954206509292319	0.391494511160488
down	CLDN4; EGFR; ASS1; ARNTL2; PROK2;	GO:0007623~circadian rhythm	5	75	6.66666666666667	0.00524316911978939	0.0469219202584542	1	1	0.781232198848619	0.954206509292319	0.396768906871534
down	AZU1; BCAP31; DEFB1;	GO:0035584~calcium-mediated signaling using intracellular calcium source	3	23	13.0434782608696	0.00549238173862476	0.0488211710099979	1	1	0.787749264046278	0.954206509292319	0.412828855833856
down	IGFBP2; CD24; IL18;	GO:0042104~positive regulation of activated T cell proliferation	3	23	13.0434782608696	0.00549238173862476	0.0488211710099979	1	1	0.787749264046278	0.954206509292319	0.412828855833856
up	NOTCH1; SOX9; DLX1; SOX8;	GO:0046533~negative regulation of photoreceptor cell differentiation	4	6	66.6666666666667	0.00556670967820772	0.637887834664366	1	1	0.999997936695675	0.999997936695675	1
up	SH3PXD2A; CD109; DCSTAMP; SBNO2;	GO:0072675~osteoclast fusion	4	6	66.6666666666667	0.00556670967820772	0.637887834664366	1	1	0.999997936695675	0.999997936695675	1
up	MYO1C; ADAMTS3; CCBE1; ROBO1;	GO:1900748~positive regulation of vascular endothelial growth factor signaling pathway	4	6	66.6666666666667	0.00556670967820772	0.637887834664366	1	1	0.999997936695675	0.999997936695675	1
down	CKB; FCGR2B; HAP1; FOXC1;	GO:0021549~cerebellum development	4	48	8.33333333333333	0.00593041078805967	0.0523621554531021	1	1	0.799493232432289	0.954206509292319	0.44277120514524
down	EGFR; CCNB1; AQP1; BTC;	GO:0048146~positive regulation of fibroblast proliferation	4	48	8.33333333333333	0.00593041078805967	0.0523621554531021	1	1	0.799493232432289	0.954206509292319	0.44277120514524
up	SYNJ1; SNCA; STXBP1; SV2A; UNC13C; UNC13A;	GO:0016082~synaptic vesicle priming	6	16	37.5	0.00601977837116496	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	S100B; CCNB1; AQP1; EIF4EBP1; STUB1; HILPDA;	GO:0071456~cellular response to hypoxia	6	111	5.40540540540541	0.00604575584398681	0.0531228750332481	1	1	0.80237129737424	0.954206509292319	0.449203803695934
down	PF4; BATF; GBP6;	GO:0042832~defense response to protozoan	3	24	12.5	0.00611573912567476	0.0531228750332481	1	1	0.8038510571793	0.954206509292319	0.449203803695934
down	CD24; ID1; ROR2;	GO:0043408~regulation of MAPK cascade	3	24	12.5	0.00611573912567476	0.0531228750332481	1	1	0.8038510571793	0.954206509292319	0.449203803695934
down	CXCL14; IL18; CMTM5;	GO:0045662~negative regulation of myoblast differentiation	3	24	12.5	0.00611573912567476	0.0531228750332481	1	1	0.8038510571793	0.954206509292319	0.449203803695934
down	MUC1; ICAM3; CLEC10A; MUC15; MUCL1; MUC4;	GO:0002223~stimulatory C-type lectin receptor signaling pathway	6	112	5.35714285714286	0.00629647841749492	0.0531228750332481	1	1	0.808462735795068	0.954206509292319	0.449203803695934
down	FUT2; IL18; KIF14; SPINK5;	GO:0030155~regulation of cell adhesion	4	49	8.16326530612245	0.00634511996863552	0.0531228750332481	1	1	0.810060245380922	0.954206509292319	0.449203803695934
down	ORM1; GSTP1; BPI; GPNMB;	GO:0032720~negative regulation of tumor necrosis factor production	4	49	8.16326530612245	0.00634511996863552	0.0531228750332481	1	1	0.810060245380922	0.954206509292319	0.449203803695934
up	INHBA; ITGB4; ITGA2; ITGA3; HMGA2;	GO:0048333~mesodermal cell differentiation	5	11	45.4545454545455	0.00643522280095432	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	FGFR3; POLR2L; FGFBP1; ESRP1; ESRP2;	GO:0008543~fibroblast growth factor receptor signaling pathway	5	79	6.32911392405063	0.00643624233715778	0.0531228750332481	1	1	0.811689388819962	0.954206509292319	0.449203803695934
down	RNASE2; RNASE3; RNASE6;	GO:0006401~RNA catabolic process	3	25	12	0.00677963011259441	0.0547346284319549	1	1	0.82034421333986	0.954206509292319	0.462832692510137
down	PYURF; TMEM246; CWH43;	GO:0006506~GPI anchor biosynthetic process	3	25	12	0.00677963011259441	0.0547346284319549	1	1	0.82034421333986	0.954206509292319	0.462832692510137
down	CRABP2; ALDH1A3; ADH7;	GO:0042573~retinoic acid metabolic process	3	25	12	0.00677963011259441	0.0547346284319549	1	1	0.82034421333986	0.954206509292319	0.462832692510137
down	NUPR1; PSEN2; WRNIP1; MGST2; PSENEN;	GO:0043085~positive regulation of catalytic activity	5	81	6.17283950617284	0.00709889264224861	0.0569637585882563	1	1	0.829950117477329	0.954206509292319	0.481682081676616
down	MAPK13; LCN2; OTUB1; XCL1; CCL26;	GO:0071347~cellular response to interleukin-1	5	81	6.17283950617284	0.00709889264224861	0.0569637585882563	1	1	0.829950117477329	0.954206509292319	0.481682081676616
down	LTF; ADRB2; TCL1A; HIGD1A;	GO:0071902~positive regulation of protein serine/threonine kinase activity	4	51	7.84313725490196	0.00723126196986512	0.057850095758921	1	1	0.831999377026656	0.954206509292319	0.48917689494059
down	CLDN5; SLC9A3R1; ALOX15B; KRT16; SLURP1; ADAM15;	GO:0030336~negative regulation of cell migration	6	116	5.17241379310345	0.00737531388994261	0.0588242557989381	1	1	0.836151845263181	0.954206509292319	0.497414333051957
down	GSTP1; CD9; OLIG1;	GO:0014003~oligodendrocyte development	3	26	11.5384615384615	0.00748467580456891	0.0591668844587716	1	1	0.838283690111718	0.954206509292319	0.500311580182428
down	TACSTD2; TJP1; CGNL1;	GO:0051497~negative regulation of stress fiber assembly	3	26	11.5384615384615	0.00748467580456891	0.0591668844587716	1	1	0.838283690111718	0.954206509292319	0.500311580182428
down	AGPAT2; IGFBP2; AOC1; HTR2A; AQP1; ALDH3A1; SLC6A11; ANXA1;	GO:0042493~response to drug	8	193	4.14507772020725	0.00748550735198095	0.0591668844587716	1	1	0.838376823421866	0.954206509292319	0.500311580182428
down	SLC9A3R1; CPE; CD24; HHEX; APCDD1; CTNNBIP1; NDRG2; AMOTL2;	GO:0016055~Wnt signaling pathway	8	194	4.12371134020619	0.00770195066997015	0.0605606451998852	1	1	0.843486510572507	0.954206509292319	0.512097136328599
up	GLI3; PAX6; NOTCH1; VEGFC; DMRTA2; SMO; DCT;	GO:0002052~positive regulation of neuroblast proliferation	7	23	30.4347826086957	0.00775158313167634	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	SNCA; WNT5A; CD151; AP2B1; NEDD4L; TFR2; MAPK8IP1;	GO:0045807~positive regulation of endocytosis	7	23	30.4347826086957	0.00775158313167634	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	KLK8; S100B; HRH2; HTR2A; ADGRF1;	GO:0007613~memory	5	83	6.02409638554217	0.00780772111569772	0.0605606451998852	1	1	0.845425560022099	0.954206509292319	0.512097136328599
down	UCHL1; GJB2; EIF4EBP1; STUB1;	GO:0002931~response to ischemia	4	53	7.54716981132075	0.00819531631990911	0.0607742558555057	1	1	0.853648998651694	0.954206509292319	0.513903415054188
down	GCNT3; GALNT18; B3GNT3; B3GNT8;	GO:0006493~protein O-linked glycosylation	4	53	7.54716981132075	0.00819531631990911	0.0607742558555057	1	1	0.853648998651694	0.954206509292319	0.513903415054188
down	MAPK13; MMP8; SPON2; IL36A;	GO:0032755~positive regulation of interleukin-6 production	4	53	7.54716981132075	0.00819531631990911	0.0607742558555057	1	1	0.853648998651694	0.954206509292319	0.513903415054188
down	ADGRG6; KLK6; MAL2; MALL;	GO:0042552~myelination	4	53	7.54716981132075	0.00819531631990911	0.0607742558555057	1	1	0.853648998651694	0.954206509292319	0.513903415054188
up	BCAR3; EDNRB; EDNRA; BCAR1;	GO:0086100~endothelin receptor signaling pathway	4	7	57.1428571428571	0.00820411907331309	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	TJP1; WWC1; AMOTL2;	GO:0035329~hippo signaling	3	27	11.1111111111111	0.00823144639297935	0.0608712002169901	1	1	0.855830215605275	0.954206509292319	0.514723170684854
up	NECAB2; SHANK3; UNC13A;	GO:1900451~positive regulation of glutamate receptor signaling pathway	3	3	100	0.00824351467153916	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	AKR7A2; GCNT3; ME1; IDH2; FUT2; SLC2A8;	GO:0005975~carbohydrate metabolic process	6	121	4.95867768595041	0.00890393567345782	0.0656033658534071	1	1	0.867136471390552	0.954206509292319	0.554738075794325
down	PSEN2; EFNA3; EFNA5; EPHB3; PSENEN;	GO:0048013~ephrin receptor signaling pathway	5	86	5.81395348837209	0.00896090560620955	0.0656033658534071	1	1	0.868628961014288	0.954206509292319	0.554738075794325
down	CLDN4; CFL1; EFNA5;	GO:0022604~regulation of cell morphogenesis	3	28	10.7142857142857	0.00902046280484348	0.0656033658534071	1	1	0.868628961014288	0.954206509292319	0.554738075794325
down	KRT17; TMEM79; FOXQ1;	GO:0031069~hair follicle morphogenesis	3	28	10.7142857142857	0.00902046280484348	0.0656033658534071	1	1	0.868628961014288	0.954206509292319	0.554738075794325
down	FOXN1; SPNS2; SIT1;	GO:0043029~T cell homeostasis	3	28	10.7142857142857	0.00902046280484348	0.0656033658534071	1	1	0.868628961014288	0.954206509292319	0.554738075794325
down	NUPR1; GSTP1; CD300A;	GO:0048147~negative regulation of fibroblast proliferation	3	28	10.7142857142857	0.00902046280484348	0.0656033658534071	1	1	0.868628961014288	0.954206509292319	0.554738075794325
up	DVL1; TBX1; WNT5A; SOX9; PTK7; SIX1; VANGL2;	GO:0090103~cochlea morphogenesis	7	24	29.1666666666667	0.0093416948676438	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	SOX9; SOX8; SIX1; SMO; SIX4; MAGED1;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	6	18	33.3333333333333	0.0094757297473782	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	ACTN4; SERPINA1; PDGFB; FN1; PDGFA; APP; SERPINE1; ITGA2B; SPARC; CLU; F5; ORM2; VEGFC; STXBP1; TGFB2; ITIH3; GAS6; CD109; FERMT3; SCG3;	GO:0002576~platelet degranulation	20	124	16.1290322580645	0.009803724841976	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	FGFR3; FOXC1; COL13A1;	GO:0001958~endochondral ossification	3	29	10.3448275862069	0.0098521983116352	0.067733863392492	1	1	0.880176117576876	0.954206509292319	0.57275343354224
down	GIPC1; CDKN2B; NPNT;	GO:0030511~positive regulation of transforming growth factor beta receptor signaling pathway	3	29	10.3448275862069	0.0098521983116352	0.067733863392492	1	1	0.880176117576876	0.954206509292319	0.57275343354224
down	XCL1; IL20RB; PGLYRP3;	GO:0032689~negative regulation of interferon-gamma production	3	29	10.3448275862069	0.0098521983116352	0.067733863392492	1	1	0.880176117576876	0.954206509292319	0.57275343354224
down	NUPR1; PHLDA3; TMEM109;	GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	3	29	10.3448275862069	0.0098521983116352	0.067733863392492	1	1	0.880176117576876	0.954206509292319	0.57275343354224
down	GRIN2D; FABP5; MGLL;	GO:0051930~regulation of sensory perception of pain	3	29	10.3448275862069	0.0098521983116352	0.067733863392492	1	1	0.880176117576876	0.954206509292319	0.57275343354224
down	EGFR; ERBB3; BTC;	GO:2000145~regulation of cell motility	3	29	10.3448275862069	0.0098521983116352	0.067733863392492	1	1	0.880176117576876	0.954206509292319	0.57275343354224
down	FUT3; KIF14; RHOD; RND3; AMOTL2;	GO:0030334~regulation of cell migration	5	89	5.61797752808989	0.010226495880607	0.070124543181305	1	1	0.88580281421892	0.954206509292319	0.592968876585969
down	EGFR; ELANE; IL18; NOTCH3;	GO:0048661~positive regulation of smooth muscle cell proliferation	4	57	7.01754385964912	0.0103674866718024	0.0707239400867142	1	1	0.887782577852232	0.954206509292319	0.598037340400567
down	PTGES; EGFR; TNNT2; S100A16;	GO:0051592~response to calcium ion	4	57	7.01754385964912	0.0103674866718024	0.0707239400867142	1	1	0.887782577852232	0.954206509292319	0.598037340400567
down	NUPR1; GATA1; PRDX4; ADAM15; BOK;	GO:0008584~male gonad development	5	90	5.55555555555556	0.0106741840865654	0.072428366900734	1	1	0.891911799144568	0.954206509292319	0.6124498699841
down	SLC1A7; GIPC1; VAMP2;	GO:0014047~glutamate secretion	3	30	10	0.0107270800977981	0.072428366900734	1	1	0.891911799144568	0.954206509292319	0.6124498699841
down	GZMA; ID1; CTNNBIP1;	GO:0043392~negative regulation of DNA binding	3	30	10	0.0107270800977981	0.072428366900734	1	1	0.891911799144568	0.954206509292319	0.6124498699841
down	EGFR; HRH2; HTR2A;	GO:0045907~positive regulation of vasoconstriction	3	30	10	0.0107270800977981	0.072428366900734	1	1	0.891911799144568	0.954206509292319	0.6124498699841
down	EGFR; ERBB3; FGFR3; MATK; EPHB3; ROR2;	GO:0018108~peptidyl-tyrosine phosphorylation	6	127	4.7244094488189	0.0110222697512915	0.0742316126107387	1	1	0.896283915807041	0.954206509292319	0.627698006148144
up	TGFB2; JAG1; SOX4; PPP1R13L; SEMA3C;	GO:0003215~cardiac right ventricle morphogenesis	5	13	38.4615384615385	0.0110534447266769	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	FN1; APP; MAPK12; CAV1; PINK1;	GO:0010952~positive regulation of peptidase activity	5	13	38.4615384615385	0.0110534447266769	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	FLRT2; COL4A1; CAV2; CAV1; FERMT1;	GO:0071711~basement membrane organization	5	13	38.4615384615385	0.0110534447266769	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	DVL1; WNT5A; EFNB2; NLGN4Y; NLGN2;	GO:0099054~presynapse assembly	5	13	38.4615384615385	0.0110534447266769	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	ACTN4; FHL3; PTPN14; TCERG1L; SND1;	GO:1903506~regulation of nucleic acid-templated transcription	5	13	38.4615384615385	0.0110534447266769	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	SLC9A3R1; GPAA1; NUPR1; CCNB1; VAMP2; OCLN;	GO:0065003~protein-containing complex assembly	6	128	4.6875	0.0114070923717833	0.0748031525247363	1	1	0.901160297370879	0.954206509292319	0.632530912935872
up	PAX6; WNT3; SFRP1; MDFI;	GO:0009950~dorsal/ventral axis specification	4	8	50	0.0115438604956408	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	F2; PDGFB; PDGFA; C1QTNF1;	GO:0010544~negative regulation of platelet activation	4	8	50	0.0115438604956408	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	PDLIM1; SLC9A1; NCKAP1L; DLG5;	GO:0030011~maintenance of cell polarity	4	8	50	0.0115438604956408	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	NRP1; SLIT1; SLIT3; SEMA3F;	GO:0048846~axon extension involved in axon guidance	4	8	50	0.0115438604956408	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	MMP2; FBN2; PPARGC1B; SFRP1;	GO:0060346~bone trabecula formation	4	8	50	0.0115438604956408	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	MELTF; FSCN1; DDR2; PDPN;	GO:0090091~positive regulation of extracellular matrix disassembly	4	8	50	0.0115438604956408	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	UCHL1; NME1; KCNQ1; PPP1R14A;	GO:0035690~cellular response to drug	4	59	6.77966101694915	0.0115804080997037	0.0748031525247363	1	1	0.903346565800268	0.954206509292319	0.632530912935872
down	LTF; BTNL3; BTNL8;	GO:0001817~regulation of cytokine production	3	31	9.67741935483871	0.0116454907907828	0.0748031525247363	1	1	0.905847921006202	0.954206509292319	0.632530912935872
down	EGFR; HTR2A; NMUR1;	GO:0007202~activation of phospholipase C activity	3	31	9.67741935483871	0.0116454907907828	0.0748031525247363	1	1	0.905847921006202	0.954206509292319	0.632530912935872
down	GIPC1; S100P; PRSS3;	GO:0043542~endothelial cell migration	3	31	9.67741935483871	0.0116454907907828	0.0748031525247363	1	1	0.905847921006202	0.954206509292319	0.632530912935872
down	CD19; FGFR3; TNFAIP8L3;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	3	31	9.67741935483871	0.0116454907907828	0.0748031525247363	1	1	0.905847921006202	0.954206509292319	0.632530912935872
down	EGFR; CCNB1; CKS2;	GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity	3	31	9.67741935483871	0.0116454907907828	0.0748031525247363	1	1	0.905847921006202	0.954206509292319	0.632530912935872
down	USP2; CCNB1; EIF4EBP1;	GO:0045931~positive regulation of mitotic cell cycle	3	31	9.67741935483871	0.0116454907907828	0.0748031525247363	1	1	0.905847921006202	0.954206509292319	0.632530912935872
down	CLDN5; DKK1; PAX9;	GO:0060325~face morphogenesis	3	31	9.67741935483871	0.0116454907907828	0.0748031525247363	1	1	0.905847921006202	0.954206509292319	0.632530912935872
up	LRP4; CALCA; MDK; NOTCH1; SOX9; SFRP1;	GO:0030279~negative regulation of ossification	6	19	31.5789473684211	0.0116491597217333	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	EGFR; NCAM1; ERBB3; FGFR3; BTC; IL5RA; IL18; EPGN; PBK;	GO:0000165~MAPK cascade	9	254	3.54330708661417	0.0120207276992296	0.0770260221504031	1	1	0.911092698050903	0.954206509292319	0.651327363435675
down	ELANE; HTR2A; ATP13A4; ATP13A5; ATP2C2;	GO:0006874~cellular calcium ion homeostasis	5	94	5.31914893617021	0.0125987073185128	0.0803973736100643	1	1	0.91849198943245	0.954206509292319	0.679835306545453
down	GSTP1; CFL1; PEMT;	GO:0043200~response to amino acid	3	32	9.375	0.0126077699524874	0.0803973736100643	1	1	0.91849198943245	0.954206509292319	0.679835306545453
up	SH3PXD2B; TBX3; TLL1; ALPL; COL5A2; PTHLH; BMP1; GNA11; SOX9; CDH11; EVC; TGFB2; SOX4; EXT1; ALX4; TP63; TRPS1; JAG2; MMP16; HOXC4; MMP14;	GO:0001501~skeletal system development	21	137	15.3284671532847	0.013354724552735	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	KLK8; HHEX; KLK6; TMPRSS4;	GO:0009611~response to wounding	4	62	6.45161290322581	0.0135645263842965	0.0829931769173509	1	1	0.92039836550018	0.954206509292319	0.70178526159871
up	CORO1A; SRPX; P2RX7;	GO:0001845~phagolysosome assembly	3	4	75	0.0135816203853193	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	MYOM2; FOXL2; MYH15;	GO:0002074~extraocular skeletal muscle development	3	4	75	0.0135816203853193	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	CD4; CAV1; DBN1;	GO:0032507~maintenance of protein location in cell	3	4	75	0.0135816203853193	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	SOX9; SOX8; FOXD1;	GO:0090184~positive regulation of kidney development	3	4	75	0.0135816203853193	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	TK1; FPGS; GDA;	GO:0006139~nucleobase-containing compound metabolic process	3	33	9.09090909090909	0.0136142155330568	0.0829931769173509	1	1	0.92039836550018	0.954206509292319	0.70178526159871
down	RHOD; ABLIM3; ARHGEF4;	GO:0030032~lamellipodium assembly	3	33	9.09090909090909	0.0136142155330568	0.0829931769173509	1	1	0.92039836550018	0.954206509292319	0.70178526159871
down	SAA1; CCL26; XCL1;	GO:0048247~lymphocyte chemotaxis	3	33	9.09090909090909	0.0136142155330568	0.0829931769173509	1	1	0.92039836550018	0.954206509292319	0.70178526159871
down	ERBB3; LCN2; BOK;	GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand	3	33	9.09090909090909	0.0136142155330568	0.0829931769173509	1	1	0.92039836550018	0.954206509292319	0.70178526159871
down	CLDN1; ASS1; GBP6; XCL1; CCL26;	GO:0071346~cellular response to interferon-gamma	5	96	5.20833333333333	0.0136435752962615	0.0829931769173509	1	1	0.92039836550018	0.954206509292319	0.70178526159871
up	SNAI2; WNT5A; NOTCH1; SOX9; HMGA2; TGFB2; CUL7; DLG5; LOXL2;	GO:0001837~epithelial to mesenchymal transition	9	40	22.5	0.013669952904354	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	WNT5A; TP63; CELSR1; VANGL2; PTK7;	GO:0001736~establishment of planar polarity	5	14	35.7142857142857	0.0140410439465249	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	WNT9A; SNAI2; PTHLH; SOX9; EFEMP1; ADAMTS7;	GO:0032331~negative regulation of chondrocyte differentiation	6	20	30	0.0141512021081104	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	TBX1; COL4A1; NR2F2; EFNB2; CDH2; LAMA1;	GO:0048514~blood vessel morphogenesis	6	20	30	0.0141512021081104	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	ADRB2; LCN2; FABP5; IL18; PEMT;	GO:0120162~positive regulation of cold-induced thermogenesis	5	97	5.15463917525773	0.0141872268462813	0.0859043093444554	1	1	0.921687438841217	0.954206509292319	0.726401620530704
down	GABRP; CLDN4; CLIC3; SLC12A1; GABRE;	GO:1902476~chloride transmembrane transport	5	97	5.15463917525773	0.0141872268462813	0.0859043093444554	1	1	0.921687438841217	0.954206509292319	0.726401620530704
down	ASS1; IGFBP2; ALDH3A1; SLC6A19;	GO:0007584~response to nutrient	4	63	6.34920634920635	0.0142708361937879	0.0862128319258582	1	1	0.921687438841217	0.954206509292319	0.729010468734147
up	AGRN; PAK4; TPM1; SPTB; CCL2; ANK1; MDK; SOX9; CNTNAP1; CCL7; FGD1; DMTN; SPTAN1; FGD6; RHOU; MICAL3; PALLD; MARK1; WASF3; CDC42BPB; AJUBA;	GO:0007010~cytoskeleton organization	21	139	15.1079136690647	0.0152394576317071	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	PDLIM1; FLNB; PDGFA; CORO1A; PFN2; RAC3; FGD1; DMTN; FSCN1; INF2; FGD6; PALLD; ARHGEF17; DLC1; TAOK2; MICALL2; SHROOM2; SMTN; MICALL1; FHL3; MICAL3; AMOTL1; RHOU;	GO:0030036~actin cytoskeleton organization	23	157	14.6496815286624	0.0155245799239507	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	FN1; COL16A1; FERMT3; FERMT2;	GO:0033622~integrin activation	4	9	44.4444444444444	0.0156448023272321	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	LRP5; MEGF8; NODAL; MIXL1;	GO:0042074~cell migration involved in gastrulation	4	9	44.4444444444444	0.0156448023272321	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	FBN2; MFAP2; FOXL2; EFEMP1;	GO:0048048~embryonic eye morphogenesis	4	9	44.4444444444444	0.0156448023272321	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	SIX1; NET1; SMO; SIX4;	GO:0051451~myoblast migration	4	9	44.4444444444444	0.0156448023272321	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	FOXN1; GATA1; USF1; POLR2L; ELF3; KLF5; TRIM29; POLR2J3; EHF;	GO:0006366~transcription by RNA polymerase II	9	266	3.38345864661654	0.0156516685240077	0.0918162829217421	1	1	0.9241322331087	0.954206509292319	0.776392909906608
down	SLC6A19; SLC6A15; SLC6A14;	GO:0003333~amino acid transmembrane transport	3	35	8.57142857142857	0.0157605981619338	0.0918162829217421	1	1	0.924672661315196	0.954206509292319	0.776392909906608
down	MAP2; CFL1; WWC1;	GO:0030010~establishment of cell polarity	3	35	8.57142857142857	0.0157605981619338	0.0918162829217421	1	1	0.924672661315196	0.954206509292319	0.776392909906608
down	EGFR; SERPINB12; MAD2L2;	GO:0042177~negative regulation of protein catabolic process	3	35	8.57142857142857	0.0157605981619338	0.0918162829217421	1	1	0.924672661315196	0.954206509292319	0.776392909906608
down	NUPR1; TGM1; PTK6;	GO:0045787~positive regulation of cell cycle	3	35	8.57142857142857	0.0157605981619338	0.0918162829217421	1	1	0.924672661315196	0.954206509292319	0.776392909906608
down	PF4; GATA1; UNC5B;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	3	35	8.57142857142857	0.0157605981619338	0.0918162829217421	1	1	0.924672661315196	0.954206509292319	0.776392909906608
down	ERBB3; PTPRZ1; KIF14; UNC5B; FOXQ1; BOK;	GO:0043524~negative regulation of neuron apoptotic process	6	138	4.34782608695652	0.015789618350936	0.0918162829217421	1	1	0.924672661315196	0.954206509292319	0.776392909906608
up	TNFRSF10B; TRPA1; F2; IFNG; IL2RA; CD4; CD3D; GP1BA; INHBA; CD3G; CCL2; CD59; EDNRB; LAMA1; BSG; LIFR; GLP1R; CCR5; P2RX7; CD80; TRBV7-1; TRBV6-8; TRBV17; TRBV25-1; TRBV7-6; TRBV29-1; TRBV7-7; TRBV14; TRBV5-7; TRBV30; TRBV6-7; TRBV7-4; TRBV16; TRBV23-1; PDCD1LG2;	GO:0007166~cell surface receptor signaling pathway	35	268	13.0597014925373	0.0158826029583251	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	PTPRZ1; RRS1; SERPINB12; PLD4;	GO:0002244~hematopoietic progenitor cell differentiation	4	66	6.06060606060606	0.0165278058639943	0.0956872971073353	1	1	0.925812473532534	0.954206509292319	0.80912597066887
down	CLDN5; IRF6; COL11A2; EPHB3;	GO:0060021~roof of mouth development	4	66	6.06060606060606	0.0165278058639943	0.0956872971073353	1	1	0.925812473532534	0.954206509292319	0.80912597066887
down	PF4; SAA1; PF4V1; GP9; CD9;	GO:0030168~platelet activation	5	102	4.90196078431373	0.0171237664528121	0.0989206639724813	1	1	0.927038309313444	0.954206509292319	0.836467124430954
down	TSPAN6; LTF; S100B; ECM1; LURAP1L; IL36A; IL36G;	GO:0043123~positive regulation of I-kappaB kinase/NF-kappaB signaling	7	183	3.82513661202186	0.0176133172353063	0.100016236611887	1	1	0.928360289077171	0.954206509292319	0.845731220106085
down	ETHE1; GSTP1; PTGES;	GO:0006749~glutathione metabolic process	3	37	8.10810810810811	0.0180862430186	0.100099961360805	1	1	0.929060938351946	0.954206509292319	0.846439191496075
down	LILRA5; NLRP10; LILRA2;	GO:2000778~positive regulation of interleukin-6 secretion	3	37	8.10810810810811	0.0180862430186	0.100099961360805	1	1	0.929060938351946	0.954206509292319	0.846439191496075
down	PHGDH; AKR7A2; MAOB; ME1;	GO:0022900~electron transport chain	4	68	5.88235294117647	0.0181495794472564	0.100240355106186	1	1	0.929060938351946	0.954206509292319	0.847626352477117
down	SLC9A3R1; GJB6; COL11A2; GJB2; KCNQ1; USH1G;	GO:0007605~sensory perception of sound	6	143	4.1958041958042	0.0183664836431564	0.101226548680445	1	1	0.929790185556304	0.954206509292319	0.85596554542291
down	DKK1; C1QA; FCGR2B;	GO:1901216~positive regulation of neuron death	3	38	7.89473684210526	0.0193166307738803	0.106241469256342	1	1	0.93134177535281	0.954206509292319	0.898371409121292
down	NUPR1; HSPB1; TRIB3; BOK;	GO:0010506~regulation of autophagy	4	70	5.71428571428571	0.0198668321542657	0.108398290007933	1	1	0.933031284242339	0.954206509292319	0.916609354354839
up	TBX3; ITGA2; SOX9; FASN; NRG1; CAV1;	GO:0030879~mammary gland development	6	22	27.2727272727273	0.0202286336057168	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	ITGAV; ITGA2; ITGB6; COL16A1; ITGB4; ITGB5;	GO:0033627~cell adhesion mediated by integrin	6	22	27.2727272727273	0.0202286336057168	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	CACNB4; JUN; CACNB3; CAV1; SCN5A; P2RX7;	GO:0051899~membrane depolarization	6	22	27.2727272727273	0.0202286336057168	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	APP; APBA1; KLC3;	GO:0008088~axo-dendritic transport	3	5	60	0.0204640678120374	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	PLAU; PDGFA; PLXNA1;	GO:0014910~regulation of smooth muscle cell migration	3	5	60	0.0204640678120374	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	NRP1; PLXNA3; SEMA3F;	GO:0021637~trigeminal nerve structural organization	3	5	60	0.0204640678120374	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	NRP1; PLXNA3; SEMA3F;	GO:0021785~branchiomotor neuron axon guidance	3	5	60	0.0204640678120374	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	SCRIB; DLG5; TP63;	GO:0030859~polarized epithelial cell differentiation	3	5	60	0.0204640678120374	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	HMGB3; INHBA; SFRP1;	GO:0045578~negative regulation of B cell differentiation	3	5	60	0.0204640678120374	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	KCNMA1; P2RX7; SHANK3;	GO:0045794~negative regulation of cell volume	3	5	60	0.0204640678120374	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	SERPINE2; PAX6; GDPD5;	GO:0048505~regulation of timing of cell differentiation	3	5	60	0.0204640678120374	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	LRP4; APP; SHANK3;	GO:0051124~synaptic growth at neuromuscular junction	3	5	60	0.0204640678120374	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	NRP1; SEMA3C; PLXNA1;	GO:0060666~dichotomous subdivision of terminal units involved in salivary gland branching	3	5	60	0.0204640678120374	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	NRP1; SIX1; SIX4;	GO:0061551~trigeminal ganglion development	3	5	60	0.0204640678120374	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	STXBP1; UNC13C; UNC13A;	GO:0099525~presynaptic dense core vesicle exocytosis	3	5	60	0.0204640678120374	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	STXBP1; UNC13A; UNC13C; ZDHHC15;	GO:0016188~synaptic vesicle maturation	4	10	40	0.0205545415393081	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	ITGA3; PCSK6; FSTL3; FSTL1;	GO:0030510~regulation of BMP signaling pathway	4	10	40	0.0205545415393081	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	AP2A2; AP2A1; AP2B1; PCSK9;	GO:0032802~low-density lipoprotein particle receptor catabolic process	4	10	40	0.0205545415393081	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	MMP14; MMP16; HMGA2; DDR2;	GO:0035988~chondrocyte proliferation	4	10	40	0.0205545415393081	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	LRP4; NLGN2; NRXN2; NLGN4Y;	GO:0097104~postsynaptic membrane assembly	4	10	40	0.0205545415393081	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	EGFR; MT1G; MT1X;	GO:0071276~cellular response to cadmium ion	3	39	7.69230769230769	0.0205921757163325	0.108398290007933	1	1	0.933933635581065	0.954206509292319	0.916609354354839
up	SEMA7A; FN1; L1CAM; MAP1B; TNFRSF12A; TRPC5; DBN1; CTTN;	GO:0045773~positive regulation of axon extension	8	36	22.2222222222222	0.0206975348521398	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	WNT9A; NDST1; EVC; ARMC9; SFRP1; DLG5; RAB34; SMO;	GO:0045880~positive regulation of smoothened signaling pathway	8	36	22.2222222222222	0.0206975348521398	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	CPE; NMU; NMUR1; PROK2; GPR1;	GO:0007218~neuropeptide signaling pathway	5	108	4.62962962962963	0.0211465072237649	0.108398290007933	1	1	0.934877956749499	0.954206509292319	0.916609354354839
down	CRYAB; AQP1; SFN; DHCR24;	GO:0043154~negative regulation of cysteine-type endopeptidase activity involved in apoptotic process	4	72	5.55555555555556	0.021680917773508	0.108398290007933	1	1	0.93586724559262	0.954206509292319	0.916609354354839
down	FCER2; FOXC1; PERP; CHAC1; NOTCH3;	GO:0007219~Notch signaling pathway	5	109	4.58715596330275	0.0218717060773064	0.108398290007933	1	1	0.936904792428089	0.954206509292319	0.916609354354839
down	FA2H; MGLL; ELOVL4;	GO:0006633~fatty acid biosynthetic process	3	40	7.5	0.0219129222505069	0.108398290007933	1	1	0.936904792428089	0.954206509292319	0.916609354354839
down	GM2A; CPTP; GLTP;	GO:0006687~glycosphingolipid metabolic process	3	40	7.5	0.0219129222505069	0.108398290007933	1	1	0.936904792428089	0.954206509292319	0.916609354354839
down	KIF14; NPNT; NLGN1;	GO:0045184~establishment of protein localization	3	40	7.5	0.0219129222505069	0.108398290007933	1	1	0.936904792428089	0.954206509292319	0.916609354354839
up	WNT9A; PCGF2; SIX1; MEGF8; MDFI; ALX4; SATB2; HOXC4; HOXC9;	GO:0048704~embryonic skeletal system morphogenesis	9	44	20.4545454545455	0.0222270758101277	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	AGPAT2; PLA2G4D; LIPH;	GO:0006654~phosphatidic acid biosynthetic process	3	41	7.31707317073171	0.0232788835488411	0.108398290007933	1	1	0.939139508689098	0.954206509292319	0.916609354354839
down	SLC6A19; SLC6A15; SLC6A14;	GO:0006865~amino acid transport	3	41	7.31707317073171	0.0232788835488411	0.108398290007933	1	1	0.939139508689098	0.954206509292319	0.916609354354839
down	HAP1; DHCR24; DUOXA1; DUOXA2;	GO:0008104~protein localization	4	74	5.40540540540541	0.0235930403032252	0.108398290007933	1	1	0.94034507930359	0.954206509292319	0.916609354354839
up	TBX1; LRP5; PDGFA; WNT5A; SOX9; SMO;	GO:0002053~positive regulation of mesenchymal cell proliferation	6	23	26.0869565217391	0.023843844090023	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	CPNE6; SYT1; NEDD4L; RNF157; SYT4; UNC13A;	GO:1903861~positive regulation of dendrite extension	6	23	26.0869565217391	0.023843844090023	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	ELANE; USF1; SERPINB13;	GO:0009411~response to UV	3	42	7.14285714285714	0.0246900427035093	0.108398290007933	1	1	0.941615815897243	0.954206509292319	0.916609354354839
down	RAMP1; CD9; CXCR1;	GO:0031623~receptor internalization	3	42	7.14285714285714	0.0246900427035093	0.108398290007933	1	1	0.941615815897243	0.954206509292319	0.916609354354839
down	CLDN4; GJB2; DSG1;	GO:0032570~response to progesterone	3	42	7.14285714285714	0.0246900427035093	0.108398290007933	1	1	0.941615815897243	0.954206509292319	0.916609354354839
down	ALOX15B; NUPR1; CAMK2N1;	GO:0045786~negative regulation of cell cycle	3	42	7.14285714285714	0.0246900427035093	0.108398290007933	1	1	0.941615815897243	0.954206509292319	0.916609354354839
up	ARVCF; CDH13; AJUBA; PCDHGC3; PCDHGB4; PCDHB2; CDH2; CDH11; CDH3;	GO:0016339~calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	9	45	20	0.0248587030373375	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	ACTN4; DMTN; SHROOM2; DPYSL3; FSCN1; LIMA1; RHOB; BAIAP2L1; ESPN;	GO:0051017~actin filament bundle assembly	9	45	20	0.0248587030373375	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	EGFR; LTF; ALOX15; ECM1;	GO:0001503~ossification	4	76	5.26315789473684	0.0256042553481173	0.108398290007933	1	1	0.944375129643462	0.954206509292319	0.916609354354839
up	JUN; MYH9; FASN; THOC5; IL31RA;	GO:0030224~monocyte differentiation	5	17	29.4117647058824	0.0261024613326891	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	TRPA1; CALCA; DBH; EDNRB; UCN;	GO:0048265~response to pain	5	17	29.4117647058824	0.0261024613326891	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	GSTP1; ANXA3; FPGS;	GO:0031100~animal organ regeneration	3	43	6.97674418604651	0.0261463538477424	0.108398290007933	1	1	0.944375129643462	0.954206509292319	0.916609354354839
down	SDC4; GPNMB; IL20RB;	GO:0042130~negative regulation of T cell proliferation	3	43	6.97674418604651	0.0261463538477424	0.108398290007933	1	1	0.944375129643462	0.954206509292319	0.916609354354839
down	BANF1; LTF; SLPI;	GO:0045071~negative regulation of viral genome replication	3	43	6.97674418604651	0.0261463538477424	0.108398290007933	1	1	0.944375129643462	0.954206509292319	0.916609354354839
up	SOX9; HMGA2; SND1; SFRP1;	GO:0010564~regulation of cell cycle process	4	11	36.3636363636364	0.0263092678201886	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	LAMA5; TGFB1I1; VEGFC; JAG2;	GO:0016331~morphogenesis of embryonic epithelium	4	11	36.3636363636364	0.0263092678201886	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	MAP2K7; PTPN1; CD40LG; WNT5A; WNT7B; MAP3K10; DAB2IP; MAPK8IP3;	GO:0007257~activation of JUN kinase activity	8	38	21.0526315789474	0.0265123067804384	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	TSPAN15; LTF; CTSG; SAA1; IGFBP2; MSLN; PSENEN;	GO:0044267~cellular protein metabolic process	7	200	3.5	0.0265830195814249	0.108398290007933	1	1	0.945876520946552	0.954206509292319	0.916609354354839
down	GM2A; ALDH1A3; TNR;	GO:0050885~neuromuscular process controlling balance	3	44	6.81818181818182	0.0276477432496142	0.108398290007933	1	1	0.94746890566195	0.954206509292319	0.916609354354839
down	NME1; ALDH3A1; DUOX2;	GO:0051591~response to cAMP	3	44	6.81818181818182	0.0276477432496142	0.108398290007933	1	1	0.94746890566195	0.954206509292319	0.916609354354839
down	SPINT1; SPINT2; SDC4; GRHL3;	GO:0001843~neural tube closure	4	78	5.12820512820513	0.0277154718770283	0.108398290007933	1	1	0.94746890566195	0.954206509292319	0.916609354354839
down	S100B; MAP2; PTPRZ1; RTN4R;	GO:0007409~axonogenesis	4	78	5.12820512820513	0.0277154718770283	0.108398290007933	1	1	0.94746890566195	0.954206509292319	0.916609354354839
up	FGF18; MMP2; MN1;	GO:0001957~intramembranous ossification	3	6	50	0.0289150808063643	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	SERPINE1; SERPINE2; CTSZ;	GO:0010757~negative regulation of plasminogen activation	3	6	50	0.0289150808063643	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	NEFL; TNC; MAP1B;	GO:0014012~peripheral nervous system axon regeneration	3	6	50	0.0289150808063643	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	JAG1; MCOLN3; PDZD7;	GO:0042491~inner ear auditory receptor cell differentiation	3	6	50	0.0289150808063643	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	CCL2; MMP14; SCRIB;	GO:0043615~astrocyte cell migration	3	6	50	0.0289150808063643	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	LRP5; COL4A1; LAMA1;	GO:0061304~retinal blood vessel morphogenesis	3	6	50	0.0289150808063643	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	SERPINE1; FAM20C; HTRA1;	GO:0097187~dentinogenesis	3	6	50	0.0289150808063643	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	NRP1; FN1; SEMA3F;	GO:1901166~neural crest cell migration involved in autonomic nervous system development	3	6	50	0.0289150808063643	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	IFNG; CCL2; PINK1;	GO:1904783~positive regulation of NMDA glutamate receptor activity	3	6	50	0.0289150808063643	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	COL11A2; FOXC1; ADAMTS14;	GO:0030199~collagen fibril organization	3	45	6.66666666666667	0.0291941103754917	0.112186974368702	1	1	0.950961878586049	0.954206509292319	0.948646239120499
down	PF4; GATA1; EIF6;	GO:0045652~regulation of megakaryocyte differentiation	3	45	6.66666666666667	0.0291941103754917	0.112186974368702	1	1	0.950961878586049	0.954206509292319	0.948646239120499
down	SCNN1A; SCNN1B; SLC28A3; SLC12A1;	GO:0035725~sodium ion transmembrane transport	4	80	5	0.0299274543012966	0.114837906039859	1	1	0.952883013694304	0.954206509292319	0.971062356269216
down	NCAM1; EPHB3; GRB7; TNR; EFNA3; EFNA5; UNC5B;	GO:0007411~axon guidance	7	206	3.39805825242718	0.030378220709926	0.116398407364593	1	1	0.952883013694304	0.954206509292319	0.984257860659826
down	DOLPP1; MGAT4B; PMM1;	GO:0006487~protein N-linked glycosylation	3	46	6.52173913043478	0.0307853289254814	0.116828016437105	1	1	0.954206509292319	0.954206509292319	0.98789060887524
down	SAA1; SAA2; GPNMB;	GO:0050918~positive chemotaxis	3	46	6.52173913043478	0.0307853289254814	0.116828016437105	1	1	0.954206509292319	0.954206509292319	0.98789060887524
down	SLC9A3R1; TRIB3; PHLDA3;	GO:0051898~negative regulation of protein kinase B signaling	3	46	6.52173913043478	0.0307853289254814	0.116828016437105	1	1	0.954206509292319	0.954206509292319	0.98789060887524
down	PLCD1; LIPH; PLA2G3; PNLIPRP3;	GO:0016042~lipid catabolic process	4	81	4.93827160493827	0.0310714326543915	0.116828016437105	1	1	0.954206509292319	0.954206509292319	0.98789060887524
up	UBB; CLU; RILPL1; TSC1; CTSZ;	GO:1901214~regulation of neuron death	5	18	27.7777777777778	0.0312399722976809	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	MAP1B; TRIM46; MARK4; GAS2L1; NCKAP5L; MTCL1; NAV1;	GO:0001578~microtubule bundle formation	7	32	21.875	0.0315108361063583	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	TBX1; TFAP2A; MMP14; MMP16; SIX1; NODAL; SIX4;	GO:0048701~embryonic cranial skeleton morphogenesis	7	32	21.875	0.0315108361063583	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	CRYAB; USF1; CD24; ALDH3A1; PSEN2; SLC2A8;	GO:0001666~response to hypoxia	6	163	3.68098159509202	0.0315193176805059	0.118197441301897	1	1	0.954206509292319	0.954206509292319	0.999470382329806
up	DVL1; FOXO3; SNAI2; LRP4; APC2; GLI3; CDH2; MDK; MCC; WNT5A; NOTCH1; SOX9; CAV1; PSMD2; DAB2IP; HECW1; SFRP1; PSMF1; PTPRU; FERMT1; BICC1; DKK3; DKK4; MAPK8IP1;	GO:0090090~negative regulation of canonical Wnt signaling pathway	24	179	13.4078212290503	0.0316517155605919	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	AGRN; SDC3; GPC4; SDC1; GPC1; HSPG2;	GO:0006027~glycosaminoglycan catabolic process	6	25	24	0.0323129608004765	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	CEACAM6; NLGN1; NECTIN4;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	3	47	6.38297872340426	0.0324212478430056	0.121063782610375	1	1	0.954206509292319	0.954206509292319	1
down	DKK1; APCDD1; CTNNBIP1;	GO:0030178~negative regulation of Wnt signaling pathway	3	47	6.38297872340426	0.0324212478430056	0.121063782610375	1	1	0.954206509292319	0.954206509292319	1
down	PLCD1; PLD4; ITPKC;	GO:0043647~inositol phosphate metabolic process	3	47	6.38297872340426	0.0324212478430056	0.121063782610375	1	1	0.954206509292319	0.954206509292319	1
down	SAA1; EPGN; CXCL17; PBK; PROK2;	GO:0000187~activation of MAPK activity	5	122	4.0983606557377	0.0327885995683762	0.122090130973926	1	1	0.954206509292319	0.954206509292319	1
up	CD4; CAV1; TRPC3; P2RX7;	GO:0010524~positive regulation of calcium ion transport into cytosol	4	12	33.3333333333333	0.0329339494932446	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	LRP5; ITGAV; SOX8; TMEM119;	GO:0033690~positive regulation of osteoblast proliferation	4	12	33.3333333333333	0.0329339494932446	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	PLXNB1; WNT5A; NLGN2; FGF13;	GO:1904862~inhibitory synapse assembly	4	12	33.3333333333333	0.0329339494932446	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	TERT; TBX3; HMGA2; SIRT6;	GO:2000648~positive regulation of stem cell proliferation	4	12	33.3333333333333	0.0329339494932446	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	KRT19; TPM1; FHOD3; LMOD2; MYOZ2; SIX4; TNNT1; MYOM2;	GO:0045214~sarcomere organization	8	40	20	0.0333730626359883	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	EPHB3; KIF14; PARVG;	GO:0034446~substrate adhesion-dependent cell spreading	3	48	6.25	0.0341016922962838	0.122335766885561	1	1	0.954206509292319	0.954206509292319	1
down	RAB27B; ORM1; PF4; CD9; ECM1;	GO:0002576~platelet degranulation	5	124	4.03225806451613	0.034720727024611	0.122335766885561	1	1	0.954206509292319	0.954206509292319	1
up	ABRA; LPAR1; GPR55; ROBO1; NET1; GPR174; P2RY10;	GO:0035025~positive regulation of Rho protein signal transduction	7	33	21.2121212121212	0.0356750892617643	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	WNT9A; TBX3; TFAP2A; WNT3; ALX4; TP63; ZNF358;	GO:0035115~embryonic forelimb morphogenesis	7	33	21.2121212121212	0.0356750892617643	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	KLK8; C1QA; TNR;	GO:0050808~synapse organization	3	49	6.12244897959184	0.035826464633619	0.122335766885561	1	1	0.954206509292319	0.954206509292319	1
down	RAMP1; SLC15A1; RAB38; VAMP2; DUOXA1; DUOXA2; ARFGAP2; TESC; CHMP4C;	GO:0015031~protein transport	9	310	2.90322580645161	0.0359085317974472	0.122335766885561	1	1	0.954206509292319	0.954206509292319	1
up	ITGAV; ITGA2; CORO1A; GAS6; FAT2;	GO:0031589~cell-substrate adhesion	5	19	26.3157894736842	0.0369674045477748	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	FGF18; GLI3; SOX9; ZNF219; LOXL2;	GO:0032332~positive regulation of chondrocyte differentiation	5	19	26.3157894736842	0.0369674045477748	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	F2; PDE6A; PRKACA; CAV1; CALCB; CALCA; TRPC5; TRPC3;	GO:0051480~regulation of cytosolic calcium ion concentration	8	41	19.5121951219512	0.0372175718518561	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	GIPC1; GRIN2D; HRH2;	GO:0048167~regulation of synaptic plasticity	3	50	6	0.0375953453134266	0.122335766885561	1	1	0.954206509292319	0.954206509292319	1
down	HTR2A; XCL1; PLCD1;	GO:0051209~release of sequestered calcium ion into cytosol	3	50	6	0.0375953453134266	0.122335766885561	1	1	0.954206509292319	0.954206509292319	1
down	ERBB3; IL18; UNC5B; ROR2;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	4	87	4.59770114942529	0.0384706562716229	0.122335766885561	1	1	0.954206509292319	0.954206509292319	1
up	ITGA2; VEGFC; CSPG4;	GO:0006929~substrate-dependent cell migration	3	7	42.8571428571429	0.0389215255755893	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	CD4; CCR5; GAS6;	GO:0019064~fusion of virus membrane with host plasma membrane	3	7	42.8571428571429	0.0389215255755893	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	TGFB2; SIX1; SIX4;	GO:0048699~generation of neurons	3	7	42.8571428571429	0.0389215255755893	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	SLIT3; PADI2; ROBO1;	GO:0070100~negative regulation of chemokine-mediated signaling pathway	3	7	42.8571428571429	0.0389215255755893	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	CD59; IL10; TGFB2;	GO:1903659~regulation of complement-dependent cytotoxicity	3	7	42.8571428571429	0.0389215255755893	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	ALOX15; CCL26; CDC42EP1;	GO:0030838~positive regulation of actin filament polymerization	3	51	5.88235294117647	0.0394080938098946	0.122335766885561	1	1	0.954206509292319	0.954206509292319	1
down	MAPK13; AQP1; PBK;	GO:0034644~cellular response to UV	3	51	5.88235294117647	0.0394080938098946	0.122335766885561	1	1	0.954206509292319	0.954206509292319	1
down	EIF4EBP1; ATP6V1C2; SLC2A8; GRB7;	GO:0008286~insulin receptor signaling pathway	4	88	4.54545454545455	0.0397934117642931	0.122335766885561	1	1	0.954206509292319	0.954206509292319	1
down	EGFR; TXN; TCL1A; MAD2L2;	GO:0033138~positive regulation of peptidyl-serine phosphorylation	4	88	4.54545454545455	0.0397934117642931	0.122335766885561	1	1	0.954206509292319	0.954206509292319	1
up	APOA2; BMP1; PRKACA; ZDHHC8;	GO:0034380~high-density lipoprotein particle assembly	4	13	30.7692307692308	0.0404427645598664	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	SHROOM2; DLG5; CELSR1; VANGL2;	GO:0045176~apical protein localization	4	13	30.7692307692308	0.0404427645598664	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	ADAMTS3; SNCA; LTBP2; B4GALT7;	GO:0097435~supramolecular fiber organization	4	13	30.7692307692308	0.0404427645598664	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	HMGA2; ANKLE1; EID3; FXR2;	GO:2001022~positive regulation of response to DNA damage stimulus	4	13	30.7692307692308	0.0404427645598664	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	NME1; ENDOU; CLEC10A; TMPRSS13; TMPRSS4; RHOV;	GO:0006897~endocytosis	6	174	3.44827586206897	0.0408488160024704	0.122335766885561	1	1	0.954206509292319	0.954206509292319	1
down	MRPS12; MRPL12; GADD45GIP1; CHCHD1;	GO:0070125~mitochondrial translational elongation	4	89	4.49438202247191	0.0411417970640505	0.122335766885561	1	1	0.954206509292319	0.954206509292319	1
down	MRPS12; MRPL12; GADD45GIP1; CHCHD1;	GO:0070126~mitochondrial translational termination	4	89	4.49438202247191	0.0411417970640505	0.122335766885561	1	1	0.954206509292319	0.954206509292319	1
down	HSPA4L; HSPB1; CHAC1;	GO:0006986~response to unfolded protein	3	52	5.76923076923077	0.0412644494929821	0.122402411979183	1	1	0.954206509292319	0.954206509292319	1
down	HTR2A; SULT1E1; KLF5;	GO:0045600~positive regulation of fat cell differentiation	3	52	5.76923076923077	0.0412644494929821	0.122402411979183	1	1	0.954206509292319	0.954206509292319	1
up	CA1; SLC4A1; CA6; SLC4A3; SLC26A2; SLC4A8; SLC26A7; CA14;	GO:0015701~bicarbonate transport	8	42	19.047619047619	0.041348307774335	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	SIX1; NR2F2; EGFL7; SIX4; IGF1R; SPOCK1; SPARC; SIX5; TFAP2A;	GO:0048856~anatomical structure development	9	50	18	0.0413650288154153	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	HSPB1; ANXA3; JUP; AQP1; ECM1;	GO:0045766~positive regulation of angiogenesis	5	131	3.81679389312977	0.0420293024314502	0.124531266463556	1	1	0.954206509292319	0.954206509292319	1
down	UCHL1; NMU; PROK2;	GO:0019233~sensory perception of pain	3	53	5.66037735849057	0.043164132485064	0.127750347265212	1	1	0.954206509292319	0.954206509292319	1
up	PDGFA; RAC3; NCKAP1L; PARVA; RHOU;	GO:0030031~cell projection assembly	5	20	25	0.0432969657543019	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	PLXNA3; DDR1; FLRT3; EIF2AK4; PLXNA1;	GO:1990138~neuron projection extension	5	20	25	0.0432969657543019	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	IFNG; JUN; ITGA2; ITGA3; SOX9; TGFB2; DOCK1;	GO:0010634~positive regulation of epithelial cell migration	7	35	20	0.0450544834154125	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	TERT; FOXO3; PDGFB; JUN; IL10; TGFB2; APLN;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	7	35	20	0.0450544834154125	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	ASS1; AQP1; KCNQ1;	GO:0071320~cellular response to cAMP	3	54	5.55555555555556	0.0451068444943221	0.132166558784695	1	1	0.954206509292319	0.954206509292319	1
down	ME1; TNFAIP8L3; TRIB3; GRHL1;	GO:0019216~regulation of lipid metabolic process	4	92	4.34782608695652	0.0453406755941795	0.132704416373208	1	1	0.954206509292319	0.954206509292319	1
down	SFN; CDKN2B; CCNB1;	GO:0000079~regulation of cyclin-dependent protein serine/threonine kinase activity	3	55	5.45454545454545	0.0470922696250873	0.136215973771742	1	1	0.954206509292319	0.954206509292319	1
down	PSEN2; PSENEN; CPE;	GO:0016485~protein processing	3	55	5.45454545454545	0.0470922696250873	0.136215973771742	1	1	0.954206509292319	0.954206509292319	1
down	GAS1; ROR2; GATA1;	GO:0045165~cell fate commitment	3	55	5.45454545454545	0.0470922696250873	0.136215973771742	1	1	0.954206509292319	0.954206509292319	1
down	OVOL1; CA2; ASS1; FOXC1;	GO:0001822~kidney development	4	94	4.25531914893617	0.0482678390096944	0.136215973771742	1	1	0.954206509292319	0.954206509292319	1
down	GSTP1; USF1; VAMP2; TRIB3;	GO:0032869~cellular response to insulin stimulus	4	94	4.25531914893617	0.0482678390096944	0.136215973771742	1	1	0.954206509292319	0.954206509292319	1
up	NRP1; TBX1; TGFB2; SEMA3C; PARVA; ROBO1;	GO:0003148~outflow tract septum morphogenesis	6	28	21.4285714285714	0.0483074057457139	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	SNAI2; SLIT3; NOTCH1; SOX9; JAG1; ROBO1;	GO:0003180~aortic valve morphogenesis	6	28	21.4285714285714	0.0483074057457139	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	SNAI2; EFNB2; PTPRK; CD109;	GO:0010839~negative regulation of keratinocyte proliferation	4	14	28.5714285714286	0.0488397130836118	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	EXTL3; EXT1; XYLT2; VANGL2;	GO:0015012~heparan sulfate proteoglycan biosynthetic process	4	14	28.5714285714286	0.0488397130836118	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	TBX1; JAG1; NPRL3; SIX1;	GO:0035909~aorta morphogenesis	4	14	28.5714285714286	0.0488397130836118	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	SOX15; NR2F2; E2F7; MDFI;	GO:0060707~trophoblast giant cell differentiation	4	14	28.5714285714286	0.0488397130836118	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
up	HMGA2; KAT2A; NODAL; SMO;	GO:2000036~regulation of stem cell population maintenance	4	14	28.5714285714286	0.0488397130836118	0.65626834265136	1	1	0.999997936695675	0.999997936695675	1
down	CCNB1; MUC1; SFN;	GO:0006977~DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest	3	56	5.35714285714286	0.0491200751664109	0.136215973771742	1	1	0.954206509292319	0.954206509292319	1
down	NUPR1; ID1; VGLL1; ARL2BP;	GO:1903508~positive regulation of nucleic acid-templated transcription	4	95	4.21052631578947	0.0497696971862589	0.136215973771742	1	1	0.954206509292319	0.954206509292319	1
